As filed with the Securities and Exchange Commission on July 20, 2018

  File No. 333-112892
  File No. 811-8108

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-4

  REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933   o

  PRE-EFFECTIVE AMENDMENT NO.   o

  POST-EFFECTIVE AMENDMENT NO. 26   x

and/or
  REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940  
o

  Amendment No. 287     x

Protective Variable Annuity
Separate Account

(Exact Name of Registrant)

Protective Life Insurance Company

(Name of Depositor)

2801 Highway 280 South

Birmingham, Alabama 35223

(Address of Depositor's Principal Executive Offices)

(205) 268-1000

Depositor's Telephone Number, including Area Code

MAX BERUEFFY, Esquire

Protective Life Insurance Company

2801 Highway 280 South

Birmingham, Alabama 35223

(Name and Address of Agent for Services)

Copy to:

STEPHEN E. ROTH, Esquire

THOMAS E. BISSET, Esquire

Eversheds Sutherland (US) LLP

700 Sixth Street, N.W., Suite 700

Washington, DC 20001-3980

It is proposed that this filing will become effective (check appropriate box):

x   immediately upon filing pursuant to paragraph (b) of Rule 485;

o   on __________ pursuant to paragraph (b) of Rule 485;

o   60 days after filing pursuant to paragraph (a)(1) of Rule 485;

o   on __________ pursuant to paragraph (a)(1) of Rule 485;

Title of Securities Being Registered: Interests in a separate
account issued through variable annuity contracts.




EXPLANATORY COMMENT

The prospectus and the statement of additional information for Values included in the Post-Effective Amendment No. 25 to the Registration Statement on Form N-4 (File Nos. 333-112892 and 811-8108) filed on April 24, 2018 pursuant to paragraph (b) of Rule 485, as supplemented on May 2, 2018, are incorporated herein by reference.




 

Life Business of Liberty Life Assurance C ompany of Boston

Table of Contents

 

 

 

 

 

 

Page

 

 

Report of Independent Auditors

1

 

 

Abbreviated Financial Statements as of and for the year ended December 31, 2017

 

 

 

Statement of Assets and Liabilities

2

 

 

Statement of Revenues and Direct Expenses

3

 

 

Notes to Abbreviated Financial Statements

4-22

 



 

REPORT OF INDEPENDENT AUDITORS

 

 

 

The Board of Directors

Protective Life Insurance Company

 

We have audited the accompanying abbreviated financial statements of the Individual Life and Annuity Business of Liberty Life Assurance Company of Boston (“Liberty Life”), which comprise the Statement of Assets and Liabilities as of December 31, 2017, and the related Statement of Revenue and Direct Expenses for the year then ended, and the related notes to the abbreviated financial statements.

 

Management’s Responsibility for the Abbreviated Financial Statements

 

Management is responsible for the preparation and fair presentation of these abbreviated financial statements in conformity with U.S. generally accepted accounting principles; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of abbreviated financial statements that are free from material misstatement, whether due to fraud or error.

 

Auditors’ Responsibility

 

Our responsibility is to express an opinion on these abbreviated financial statements based on our audit. We conducted our audit in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the abbreviated financial statements are free from material misstatement.

 

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the abbreviated financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the abbreviated financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the abbreviated financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the abbreviated financial statements.

 

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

 

Opinion

 

In our opinion, the abbreviated financial statements referred to above present fairly, in all material respects, the Statement of Assets and Liabilities of Liberty Life as of December 31, 2017 and its related Statement of Revenue and Direct Expenses for the year ended in accordance with U.S. generally accepted accounting principles.

 

Basis of Accounting

 

As described in Note 1 to the abbreviated financial statements, the abbreviated financial statements were prepared for the purpose of complying with the rules and regulations of the Securities and Exchange Commission for inclusion in a Form 8-K/A to be filed by Protective Life Insurance Company and are not intended to be a complete presentation of Liberty Life’s assets, liabilities, revenues and expenses. Our opinion is not modified with respect to this matter.

 

 

/s/ ERNST & YOUNG LLP

 

Boston, Massachusetts

July 13, 2018

 

1



 

Individual Life and Annuity Business of Liberty Life Assurance Company of Boston

Statement of Assets and Liabilities

(in thousands)

 

 

 

December 31, 2017

 

Assets

 

 

 

Investments:

 

 

 

Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $12,397,945)

 

 

$

13,647,301

 

 

Equity securities available-for-sale, at estimated fair value (cost: $2,093)

 

 

 

2,396

 

 

Mortgage loans (net of valuation allowances of $556)

 

 

 

834,606

 

 

Policy loans

 

 

 

131,155

 

 

Other long-term investments

 

 

 

95,789

 

 

 

 

 

 

 

 

 

Total investments

 

 

 

14,711,247

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

 

448,105

 

 

Accrued investment income

 

 

 

150,180

 

 

Accounts and premiums receivable

 

 

 

2,408

 

 

Reinsurance receivables

 

 

 

324,537

 

 

Deferred policy acquisition costs

 

 

 

452,175

 

 

Other assets

 

 

 

23,878

 

 

Separate account assets

 

 

 

99,333

 

 

 

 

 

 

 

 

 

Total assets

 

 

$

16,211,863

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Future policy benefits

 

 

$

5,901,753

 

 

Policyholder account balances

 

 

 

7,333,659

 

 

Other policy claims and benefits payable

 

 

 

41,478

 

 

Policyholder dividends payable

 

 

 

95,168

 

 

Payables for collateral under securities loaned

 

 

 

341,520

 

 

Other liabilities

 

 

 

145,424

 

 

Separate account liabilities

 

 

 

99,333

 

 

 

 

 

 

 

 

 

Total liabilities

 

 

 

13,958,335

 

 

 

 

 

 

 

 

 

Net assets

 

 

$

2,253,528

 

 

 

2



 

Individual Life and Annuity Business of Liberty Life Assurance Company of Boston

Statement of Revenues and Direct Expenses

(in thousands)

 

 

 

Year Ended

December 31, 2017

 

Revenues

 

 

 

Premiums

 

 

$

485,794

 

 

Reinsurance ceded

 

 

 

(93,561

)

 

 

 

 

 

 

 

 

Premiums, net of reinsurance ceded

 

 

 

392,233

 

 

 

 

 

 

 

 

 

Net investment income

 

 

 

624,217

 

 

Universal life and investment-type product policy fees

 

 

 

104,506

 

 

Cost of insurance

 

 

 

80,690

 

 

Other income

 

 

 

31,956

 

 

Net realized investment gains (losses):

 

 

 

 

 

 

Other-than-temporary impairment on fixed maturity and equity securities

 

 

 

(563

)

 

Other net investment gains

 

 

 

51,435

 

 

 

 

 

 

 

 

 

Total net realized investment gains

 

 

 

50,872

 

 

 

 

 

 

 

 

 

Total revenues

 

 

$

1,284,474

 

 

 

 

 

 

 

 

 

Benefits, Losses and Expenses

 

 

 

 

 

 

Policyholder benefits and claims

 

 

$

698,609

 

 

Interest credited to policyholder account balances

 

 

 

236,628

 

 

Amortization of policy acquisition costs

 

 

 

77,431

 

 

Policyholder dividends

 

 

 

5,030

 

 

Other expenses

 

 

 

100,684

 

 

 

 

 

 

 

 

 

Total benefits, losses and expenses

 

 

 

1,118,382

 

 

 

 

 

 

 

 

 

Revenue in excess of direct expenses

 

 

$

166,092

 

 

 

3



 

Notes to Abbreviated Financial Statements

 

 

1.       Description of the Transaction and Basis of Presentation

 

 

On May 1, 2018, The Lincoln National Life Insurance Company (“Lincoln Life”) completed its previously announced acquisition (the “Closing”) of Liberty Mutual Group Inc.’s (“Liberty”) Group Benefits Business (the “Group Business”) and Individual Life and Annuity Business (the “Life Business”) through the acquisition of all of the issued and outstanding capital stock of Liberty Life Assurance Company of Boston (the “Company”).

 

In connection with the Closing and pursuant to the Master Transaction Agreement, dated January 18, 2018 (the “Master Transaction Agreement”), previously reported in the Current Reports of Protective Life Corporation (“Protective”) and Protective Life Insurance Company (“Protective Life”) on Form 8-K filed on January 23, 2018, Protective Life, a wholly owned subsidiary of Protective and Protective Life and Annuity Insurance Company (“PLAIC”), a wholly-owned subsidiary of Protective Life, entered into reinsurance agreements (the “Reinsurance Agreements”) and related ancillary documents (including administrative services agreements and transition services agreements) providing for the reinsurance and administration of the Life Business.  The terms of the Reinsurance Agreement resulted in an acquisition of the Company’s Life Business by Protective Life, in accordance with Accounting Standards Codification (“ASC”) Topic 805, Business Combinations .

 

 

Basis of Presentation

 

The accompanying Statement of Assets and Liabilities as of December 31, 2017 and the related Statements of Revenues and Direct Expenses for the year ended December 31, 2017 (collectively, the “Abbreviated Financial Statements”) of the Company’s Life Business have been prepared for the purpose of complying with Rule 3-05 of Regulation S-X of the United States Securities and Exchange Commission and for inclusion in Protective Life’s filings with the United States Securities and Exchange Commission.

 

The Abbreviated Financial Statements have been prepared in accordance with approval received by Protective Life from the United States Securities and Exchange Commission permitting Protective Life to substitute Abbreviated Financial Statements for the full financial statements required by Rule 3-05 of Regulation S-X. The Abbreviated Financial Statements include the assets and liabilities associated with the Company’s Life Business as well as all revenue and costs directly associated with the revenue producing activities of the Company’s Life Business and excludes costs not directly involved in the revenue producing activity, such as corporate overhead and income taxes.  Amounts reported in the Abbreviated Financial Statements are reported at the historical basis of the Company’s Life Business.

 

During the period presented in the Abbreviated Financial Statements, the Company was 90% owned by Liberty Mutual Insurance Company and 10% owned by Liberty Mutual Fire Insurance Company. Liberty Mutual Insurance Company and Liberty Mutual Fire Insurance Company are both wholly owned by Liberty. Liberty is wholly owned by LMHC Massachusetts Holdings Inc., which is wholly owned by Liberty Mutual Holding Company, Inc.  As a wholly owned subsidiary of Liberty, the Company did not maintain dedicated administrative support functions related to the Company.  Further, the Company’s assets and operating results were integrated with those of Liberty.  Based upon these factors, there is no reasonable basis to allocate corporate overhead and income tax expense to the Life Business acquired by Protective.  Accordingly, the Abbreviated Financial Statements do not purport to present the financial position or operating results of the Company that would have resulted from the Company’s Life Business operating as a standalone, separate business.

 

4



 

2.       Summary of Significant Accounting Policies

 

Use of Estimates

 

The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Abbreviated Financial Statements and accompanying notes. Actual results could differ from those estimates.

 

Fixed Maturity and Equity Securities

 

Fixed maturity and equity securities, which is comprised of non-redeemable preferred stocks, are classified as available-for-sale (“AFS”) and are reported at their estimated fair value. In accordance with U.S. GAAP, unrealized investment gains and losses on these securities are typically reflected as a separate component of other comprehensive income (loss) (“OCI”), net of policy-related amounts and deferred income taxes.  However, due to the approval granted by the United States Securities and Exchange Commission, unrealized gains and losses are reported as a component of net assets in the Statement of Assets and Liabilities due to the omission of equity balances from the Abbreviated Financial Statements.

 

Interest income and prepayment fees are recognized when earned. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts and is based on the estimated economic life of the securities, which for mortgage-backed and asset-backed securities considers the estimated timing and amount of prepayments of the underlying loans. The amortization of premium and accretion of discount of fixed maturity securities also takes into consideration call and maturity dates. Dividends on equity securities are recognized when declared. These amounts are presented in net investment income in the Statement of Revenues and Direct Expenses.

 

All security transactions are recorded on a trade date basis. Investment gains and losses on sales are determined on a specific identification basis.  Unrealized losses that are other-than-temporary are recognized as realized losses. Fixed income, public equity securities, private equity securities and private equity co-investment securities are reviewed for impairment on a quarterly basis. Securities are reviewed for both quantitative and qualitative considerations including, but not limited to, (1) the extent of the decline in fair value below book value, (2) the duration of the decline, (3) significant adverse changes in the financial condition or near term prospects for the investment or issuer, (4) significant changes in the business climate or credit ratings of the issuer, (5) general market conditions and volatility, (6) industry factors, and (7) the past impairment history of the security holding or the issuer.

 

For fixed maturity securities that the Company does not intend to sell or for which it is more likely than not that the Company would not be required to sell before an anticipated recovery in value, the Company separates impairments into credit loss and non-credit loss components. The determination of the credit loss component of the impairment charge is based on the best estimate of the present value of the cash flows expected to be collected from the debt security compared to its amortized cost, and is reported as part of net realized investment gains (losses). The non-credit component, the residual difference between the credit impairment component and the fair value, is recognized in net assets in the Statement of Assets and Liabilities. The factors considered in making an evaluation of credit versus non-credit other-than-temporary impairment include the following: (1) failure of the issuer of the security to make scheduled interest or principal payments (including the payment structure of the debt security and the likelihood the issuer will be able to make payments that increase in the future), (2) performance indicators of the underlying assets in the security (including default and delinquency rates), (3) vintage, (4) geographic concentration, and (5) industry analyst reports, sector credit ratings and volatility of the security’s fair value.

 

For equity and fixed maturity investments the Company intends to sell or for which it is more likely than not that the Company will be required to sell before an anticipated recovery in value, the full amount (fair value less amortized cost) of the impairment is included in net realized investment gains (losses).

 

Upon recognizing an other-than-temporary impairment, the new cost basis of the investment is the previous amortized cost basis less the other-than-temporary impairment recognized in net realized investment gains (losses). The new cost basis is not adjusted for any subsequent recoveries in fair value; however, for fixed

 

5



 

maturity investments, the difference between the new cost basis and the expected cash flows is accreted to net investment income over the remaining expected life of the investment.

 

For the mortgage-backed fixed maturity securities, a constant effective yield is used to recognize income which considers anticipated prepayments over the economic life of the security. The mortgage backed portfolio is accounted for under the retrospective method and prepayment assumptions are based on market expectations. When actual prepayments differ significantly from anticipated prepayments, the effective yield is recalculated to reflect actual payments to date and anticipated future payments, and any resulting adjustment is included in net investment income.

 

Mortgage Loans

 

Mortgage loan investments are comprised entirely of commercial mortgage loans. Mortgage loans are stated at unpaid principal balance, adjusted for any unamortized premium or discount, deferred fees or expenses, and are net of valuation allowances. Interest income is recognized using an effective yield method giving effect to amortization of premiums and accretion of discounts.  Interest income and prepayment fees are recognized when earned and are presented as a component of net investment income in the Statement of Revenues and Direct Expenses.

 

Other Investments

 

All Variable Interest Entities (“VIEs”) for which the Company is the primary beneficiary are consolidated into the Company’s financial statements.  For unconsolidated VIEs, the Company uses the equity method of accounting when it has more than a minor ownership interest or more than a minor influence over the investee’s operations.

 

Other investments are primarily comprised of limited partnerships, which are accounted for under the equity method and, accordingly, the share of earnings attributed to the Life Business are included in net investment income. Recognition of limited partnerships is delayed due to the availability of the related financial statements, as private equity and other funds are generally on a three-month delay.

 

Policy Loans

 

Policy loans are stated at unpaid principal balances. Interest income is recorded as earned using the contractual interest rate. Generally, accrued interest is capitalized on the policy’s anniversary date. Valuation allowances are not established for policy loans, as they are fully collateralized by the cash surrender value of the underlying insurance policies. Any unpaid principal and accrued interest is deducted from the cash surrender value or the death benefit prior to settlement of the insurance policy .

 

Cash and Cash Equivalents

 

Cash equivalents are short term, highly liquid investments that are both readily convertible into known amounts of cash and so near to maturity that they present insignificant risk of changes in value due to changing interest rates. Cash equivalents include debt securities purchased with maturities of three months or less at acquisition and are carried at amortized cost, which approximates fair value.

 

Securities Lending

 

Participation in a securities lending program is used to generate additional income, whereby certain domestic fixed income securities are loaned for a short period of time from the portfolio of the Life Business to qualifying third parties via a lending agent. Terms of the agreement are for borrowers of these securities to provide collateral of at least 102% of the market value of the loaned securities. Acceptable collateral may be in the form of cash or permitted securities as outlined in the securities lending agreement. The market value of the loaned securities is monitored and additional collateral is obtained if the market value of the collateral falls below 102% of the market value of the loaned securities. Under the terms of the securities lending program, the lending agent indemnifies the Company against borrower defaults. The loaned securities remain a recorded asset of the Company’s Life Business; however, a liability for the amount of cash collateral held, representing an obligation to return the collateral related to the loaned securities has been recorded.

 

6



 

Deferred Policy Acquisition Costs and Deferred Sales Inducements

 

Deferred policy acquisition costs (DAC) are the costs of acquiring new business which vary with, and are primarily related to, the production of new business. Such costs include commissions, certain costs of policy underwriting and variable agency expenses.  Sales inducement costs associated with certain single premium annuities are also deferred and reported within other assets in the Statement of Assets and Liabilities.  Sales inducements are amounts that are credited to policyholders’ account balances primarily as an inducement to purchase the contract.

 

Acquisition costs related to traditional life insurance, to the extent recoverable from future policy revenues, are deferred and amortized over the premium-paying period of the related policies using assumptions consistent with those used in computing policy benefit reserves.

 

Acquisition costs for participating, dividend-paying traditional contracts, to the extent recoverable from future gross margins, are deferred and amortized generally in proportion to the present value of future gross margins.  For universal life insurance and investment products, to the extent recoverable from future gross profits, deferred policy acquisition costs are amortized generally in proportion to the present value of expected gross profits arising principally from surrender charges and investment, mortality and expense margins.

 

The amortization of DAC is analyzed for the differences between expected and actual gross margins or gross profits, as applicable, including consideration of the effect of the timing and amount of realized and unrealized investment gains and losses. The amortization of DAC is adjusted in situations where differences between actual and expected amounts are material. Deferred policy acquisition costs are adjusted for amounts relating to unrealized gains and losses on fixed maturity and equity securities of the Life Business that the Company has designated as available for sale as if these gains (losses) had been realized. This adjustment, net of tax, while typically included as a component of net unrealized gains or losses in accumulated other comprehensive income (loss) in accordance with U.S. GAAP, are included as a component of net assets in the Statement of Assets and Liabilities.

 

The deferred sales inducement asset (SIA) is amortized over the life of the policy in relation to estimated gross profits similar to methodology described above for amortizing DAC that is associated with universal life insurance products.  The SIA is recoverable from estimated future gross profits.

 

Recognition of Traditional Life Premium Revenue and Related Expenses

 

Premiums on traditional life insurance policies are recognized as revenue when due.  Benefits and expenses are associated with premiums to result in the recognition of profits over the life of the policies. This association is accomplished by providing liabilities for future policy benefits and the deferral and subsequent amortization of acquisition costs.

 

When premiums are due over a significantly shorter period than the period over which policyholder benefits are incurred, any excess profit is deferred and recognized into earnings in proportion to insurance in-force or, for annuities, the amount of expected future policy benefit payments.  The deferred balance is included as a component of future policy benefits in the Statement of Assets and Liabilities.

 

Recognition of Universal Life Revenue and Policy Account Balances

 

Revenues from universal life policies represent investment income from the related invested assets and amounts assessed against policyholders’ account balances. Included in such assessments are mortality charges, surrender charges and administrative fees. Policy account balances consist of consideration received plus credited interest, less accumulated policyholder charges, assessments and withdrawals. Credited interest rates were between 3.0% and 6.0% in 2017.

 

Through its Life Business the Company writes certain annuity and structured settlement contracts without mortality risk which are accounted for as investment contracts. Revenues for investment contracts consist of investment income from the related invested assets, with profits recognized to the extent investment income earned exceeds the amount credited to the contract. Policy account balances consist of consideration received plus credited interest less policyholder withdrawals. Credited interest rates for deferred annuity contracts were

 

7



 

between 1.00% and 4.5% in 2017. Credited interest rates for structured settlement and other immediate annuity contracts were between 1% and 12% for the year ended 2017.

 

Future Policy Benefits

 

Liabilities for future policy benefits for traditional life policies have been computed using the net level premium method based on estimated future investment yield, mortality and withdrawal experience. Interest rate assumptions were between 4.50% and 10.30% for 2017.

 

Mortality assumptions have been calculated principally on an experience multiple applied to the 1955-60 and 1965-70 Select and Ultimate Basic Tables for issues prior to 1986, the 1986 Bragg Non-Smoker/Smoker Select and Ultimate Basic Tables for 1986 to 1992 issues, the 1991 Bragg Non-Smoker/Smoker Select and Ultimate Basic Tables for 1993-1998 issues, the 1975-1980 Select and Ultimate Basic Tables for 1999-2006 issues, and the 2001 Valuation Basic Table for 2007 and subsequent issues. Withdrawal assumptions generally are based on the Company’s experience.

 

The liability for future policy benefits with respect to structured settlement contracts with life contingencies is determined based on interest crediting rates between 1% and 12%.  The structured settlement and other immediate annuity business mortality assumptions for issues through 1999 are based on the 1971 IAM Tables. Mortality assumptions for issues from 2000 to present are based on either the Annuity 2000 Table or an experience adjusted Annuity 2000 Table. An additional liability is recorded if the expected margin on the contracts in force is less than the unrealized gains on assets backing the future policy benefits.

 

Other Policy Claims and Benefits Payable

 

Policy and contract claims principally include claims in course of settlement and claims incurred but not reported, which are determined based on a formula derived as a result of the Company’s past experience. Claims liabilities may be more or less than the amounts paid when the claims are ultimately settled. Such differences represent changes in estimates and have been recorded in the Statement of Revenues and Direct Expenses.

 

Reinsurance

 

For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The Company reviews all contractual features, including those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims.

 

All assets and liabilities related to reinsurance ceded contracts are reported on a gross basis in the Statement of Assets and Liabilities. Prospective reinsurance premiums, losses and loss adjustment expenses are accounted for on a basis consistent with the terms of the reinsurance contracts. The Statement of Revenues and Direct Expenses reflect premiums, benefits, losses and expenses net of reinsurance ceded. Amounts recoverable from reinsurers include unpaid losses estimated in a manner consistent with the claim liabilities associated with the reinsured business. The Company evaluates reinsurance collectability and a provision for uncollectible reinsurance is recorded when deemed necessary.

 

Participating Policies

 

Participating policies approximate 4% of ordinary life insurance in force at December 31, 2017 and 8% of ordinary insurance premium revenue in 2017. Dividends to participating policyholders are calculated as the sum of the difference between the assumed mortality, interest and loading, and the actual experience of the Company relating to participating policyholders. As a result of statutory regulations, the major portion of earnings from participating policies inures to the benefit of the participating policyholders and is not available to stockholders. Undistributed earnings of the participating block of business is represented by the liability for policyholder dividends payable in the Statement of Assets and Liabilities. The payment of dividends to policyholders is further restricted by insurance laws of the state of New Hampshire claims are settled.

 

8



 

Separate Accounts

 

Separate and variable accounts represent funds for which investment income and investment gains and losses accrue directly to the policyholders who bear the investment risk. Each account has specific investment objectives, and the assets are carried at fair value. The assets of each account are legally segregated and are not subject to claims that arise out of any other business of the Company. The liabilities of these accounts are equal to the account assets. Investment income, realized investment gains (losses), and policyholder account deposits and withdrawals related to separate accounts are excluded from the Statement of Revenues and Direct Expenses. The fees earned for administrative and contract holder maintenance services performed for these separate accounts are included in other income in the Statement of Revenues and Direct Expenses.

 

Accounting Pronouncements Not Yet Adopted

 

Accounting Standards Updates (“ASU”) No. 2014-09 - Revenue from Contracts with Customers (Topic 606). This Update provides for significant revisions to the recognition of revenue from contracts with customers across various industries. Under the new guidance, entities are required to apply a prescribed 5-step process to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Update was originally effective for annual and interim periods beginning after December 15, 2017. However, in August 2015, the FASB issued ASU No. 2015-14 - Revenues from Contracts with Customers: Deferral of the Effective Date , to defer the effective date of ASU No. 2014-09 by one year to annual and interim periods beginning after December 15, 2018.  The accounting for revenues associated with insurance products is not within the scope of this Update.  As such, there will be no impact upon adoption.

 

ASU No. 2016-01 - Financial Instruments - Recognition and Measurement of Financial Assets and Financial Liabilities.   The amendments in this Update address certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. Most notably, the Update requires that equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) be measured at fair value with changes in fair value recognized in net income. The Update also introduces a single-step impairment model for equity investments without a readily determinable fair value. Additionally, the Update requires changes in instrument-specific credit risk for fair value option liabilities to be recorded in other comprehensive income. The amendments in this Update are effective for annual and interim periods beginning after December 15, 2018 and will be applied on a modified retrospective basis.

 

ASU No. 2016-13 - Financial Instruments-Credit Losses: Measurement of Credit Losses on Financial Instruments.   The amendments in this Update introduce a new current expected credit loss (“CECL”) model for certain financial assets, including mortgage loans and reinsurance receivables. The new model will not apply to debt securities classified as available-for-sale. For assets within the scope of the new model, an entity will recognize as an allowance against earnings its estimate of the contractual cash flows not expected to be collected on day one of the asset’s acquisition. The allowance may be reversed through earnings if a security recovers in value. This differs from the current impairment model, which requires recognition of credit losses when they have been incurred and recognizes a security’s subsequent recovery in value in other comprehensive income. The Update also makes targeted changes to the current impairment model for available-for-sale debt securities, which comprise the majority of the Company’s invested assets. Similar to the CECL model, credit loss impairments will be recorded in an allowance against earnings that may be reversed for subsequent recoveries in value. The amendments in this Update are effective for annual and interim periods beginning after December 15, 2020 on a modified retrospective basis.  Policies and processes are being reviewed to ensure compliance with the requirements in this Update, upon adoption, and assessing the impact this standard will have on operations and financial results.

 

ASU No. 2017-08 - Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities.   The amendments in this Update require that premiums on callable debt securities be amortized to the first call date. This is a change from current guidance, under which premiums are amortized to the maturity date of the security. The amendments are effective for annual and interim periods beginning after December 31, 2019, and early adoption is permitted. Transition will be through a modified retrospective approach in which the cumulative effect of application is recorded to retained earnings at the beginning of the annual period in which an entity adopts the revised guidance. Internal systems and processes

 

9



 

are being reviewed to determine the financial and operational impact of implementing the Update, as well as to determine whether early adoption of the revised guidance is practicable.

 

 

3.                         Investments

 

Components of Net Investment Income:

 

 

 

Year Ended

 

 

 

December 31,

 

 

 

2017

 

Taxable interest income

 

$

591,614

 

Dividends

 

40

 

Limited partnerships, limited liability companies and

 

 

 

other equity method investments

 

6,735

 

Commercial mortgage loans

 

33,692

 

Other investments

 

7,132

 

Gross investment income

 

639,213

 

Investment expenses*

 

(14,996

)

 

 

 

 

Net investment income

 

$

624,217

 

 

 

*Fees paid to external managers are included within the components of gross investment income.

 

Components of Net Realized Gains (Losses):

 

 

 

Year Ended

 

 

 

December 31,

 

 

 

2017

 

 

 

 

 

Fixed maturities:

 

 

 

Gross realized gains

 

$

56,440

 

Gross realized losses

 

(6,202

)

Equities:

 

 

 

Gross realized gains

 

35

 

Gross realized losses

 

(76

)

Other:

 

 

 

Gross realized gains

 

823

 

Gross realized losses

 

(148

)

 

 

 

 

Net realized gains (losses)

 

$

50,872

 

 

 

During the year ended December 31, 2017, impairment charges in the amount of $563 were recorded as a component of net realized gains (losses) in the Statement of Revenues and Direct Expenses.

 

During the year ended December 31, 2017, proceeds from sales of fixed maturities available for sale were $479,388.  The gross realized gains (losses) on sales of fixed maturities available for sale totaled $51,601 and $(3,388) in 2017.  During the year ended December 31, 2017, proceeds from sales of equities available for sale were $1,988.  The gross realized gains (losses) on sales of equities available for sale totaled $31 and $(2) in 2017.

 

Available for Sale Investments:

 

The amortized cost, gross unrealized gains and losses and fair values of available for sale investments as of December 31, 2017 are as follows:

 

10



 

 

 

December 31, 2017

 

 

 

 

 

Gross

 

Gross

 

Estimated

 

 

 

Amortized

 

Unrealized

 

Unrealized

 

Fair

 

 

 

Cost

 

Gains

 

Losses

 

Value

 

 

 

 

 

 

 

 

 

 

 

U.S. government and agency securities

 

$

322,882

 

$

90,375

 

$

(31

)

$

413,226

 

Residential MBS*

 

357,230

 

30,074

 

(493

)

386,811

 

Commercial MBS*

 

253,290

 

4,980

 

(2,744

)

255,526

 

Other MBS* and ABS**

 

216,388

 

3,523

 

(638

)

219,273

 

U.S. state and municipal

 

3,043,149

 

331,361

 

(4,625

)

3,369,885

 

Corporate and other

 

8,088,115

 

822,911

 

(28,500

)

8,882,526

 

Foreign government securities

 

116,891

 

4,468

 

(1,305

)

120,054

 

 

 

 

 

 

 

 

 

 

 

Total fixed maturities

 

12,397,945

 

1,287,692

 

(38,336

)

13,647,301

 

 

 

 

 

 

 

 

 

 

 

Preferred stock

 

2,093

 

303

 

-

 

2,396

 

 

 

 

 

 

 

 

 

 

 

Total equity securities

 

2,093

 

303

 

-

 

2,396

 

 

 

 

 

 

 

 

 

 

 

Total securities available for sale

 

$

12,400,038

 

$

1,287,995

 

$

(38,336

)

 

$

13,649,697

 

 

*Mortgage-backed securities (“MBS”)

** Asset-backed securities (“ABS”)

 

Approximately 57% of the mortgage and asset-backed fixed maturity portfolio is explicitly backed by the U.S. government (Government National Mortgage Association “GNMA” and Small Business Association “SBA”) or by government-sponsored entities (Federal Home Loan Mortgage Corporation “FHLMC” and Federal National Mortgage Association “FNMA”).  Approximately 82% of the holdings are rated AAA.  The commercial MBS portfolio is well diversified and of high quality with approximately 77% rated AAA.

 

As of December 31, 2017, no single issuer, excluding U.S. Treasuries, agency securities and MBS, accounted for more than 10% of invested assets.

 

As of December 31, 2017, securities carried at $6,028 were on deposit with state regulatory authorities as required by law.

 

As of December 31, 2017, the fair values of fixed maturity securities and equity securities loaned were approximately $378,184.  Cash and short-term investments received as collateral in connection with the loaned securities were approximately $341,520 as of December 31, 2017. Investments other than cash and short-term investments received as collateral in connection with the loaned securities were approximately $52,720 as of December 31, 2017.

 

The amortized cost and fair value of fixed maturities as of December 31, 2017, by contractual maturity are as follows:

 

 

 

 

 

Estimated

 

 

Amortized

 

Fair

 

 

Cost

 

Value

 

 

 

 

 

Due to mature:

 

 

 

 

One year or less

 

$

223,809

 

$

227,446

Over one year through five years

 

1,795,898

 

1,885,840

Over five years through ten years

 

2,520,617

 

2,653,383

Over ten years

 

7,030,713

 

8,019,022

 

11



 

MBS and ABS of government and corporate agencies

 

826,908

 

861,610

 

 

 

 

 

 

 

Total fixed maturities

 

$

12,397,945

 

$

13,647,301

 

 

Expected maturities may differ from contractual maturities as borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

 

The following tables summarizes the gross unrealized losses and fair value of fixed maturity securities by the length of time that individual securities have been in a continuous unrealized loss position as of December 31, 2017 and that are not deemed to be other-than-temporarily impaired.

 

 

 

Less Than 12 Months

 

12 Months or Longer

 

 

 

 

Estimated

 

 

 

Estimated

 

 

 

 

Fair Value of

 

 

 

Fair Value of

 

 

 

 

Investments with

 

 

 

Investments with

 

 

Unrealized

 

Unrealized

 

Unrealized

 

Unrealized

December 31, 2017

 

 

Losses

 

Losses

 

Losses

 

Losses

 

 

 

 

 

 

 

 

 

U.S. government and agency securities

 

$

(31

)

$

2,819

 

$

-

 

$

-

Residential MBS

 

(286

)

19,413

 

(207

)

4,246

Commercial MBS

 

(1,196

)

97,631

 

(1,548

)

29,496

Other MBS and ABS

 

(334

)

65,488

 

(304

)

6,166

U.S. state and municipal

 

(1,950

)

124,768

 

(2,675

)

71,884

Corporate and other

 

(7,735

)

484,300

 

(20,765

)

394,573

Foreign government securities

 

(242

)

18,621

 

(1,063

)

27,328

 

 

 

 

 

 

 

 

 

Total fixed maturities

 

$

(11,774

)

 

$

813,040

 

$

(26,562

)

 

$

533,693

 

 

As of December 31, 2017, there were 160 securities that were in an unrealized loss position for 12 months or longer.  The Company monitors the difference between the amortized cost and estimated fair value of fixed maturity securities to ascertain whether declines in value are temporary in nature. In addition, the Company also monitors its intent and ability to hold certain equity securities for a period of time that is sufficient to allow for any anticipated recovery in fair value. The Company currently does not have the intent to sell and has determined it is not more likely than not that it would be required to sell these fixed maturity securities before recovery.

 

Equity Method Investments

 

The Life Business of the Company holds investments in traditional and private equity partnerships which invest in energy and real estate joint ventures.  The portion of these investments accounted for under the equity method of accounting was $95,789 as of December 31, 2017.  The Company believes these investments offer the potential for superior long-term returns and are appropriate in the overall context of a diversified portfolio maintained for the Life Business.  The Company’s investments are generally of a passive nature in that the Company does not participate in the management of the entities.  The aggregate summarized financial data below reflects the latest available information and is as of, and for, the year ended December 31, 2017. Aggregate total assets and liabilities were $95,789 and $0, respectively.  Aggregate net income reported as a component of net investment income in the Statement of Revenues and Direct Expenses was approximately $6,735.  Aggregate net income for these entities is comprised of investment income, including recurring investment income and realized and unrealized investment gains (losses).

 

Variable Interest Entities

 

The Life Business holds certain investments in energy, private equity and real estate limited partnerships and other entities subject to VIE analysis under the VIE subsections of ASC 810, Consolidation . These investments are analyzed to determine whether it is a VIE, and if so, whether the Life Business is the primary beneficiary or a significant interest holder based on a qualitative and quantitative assessment. The design of the entity, the risks to

 

12



 

which the entity was designed to expose the variable interest holder to and the extent of the variable interest held by the Life Business in the VIE.

 

The Life Business has variable interests in VIEs for which it is not the primary beneficiary and accounts for these VIEs under the equity method in accordance with ASC 323,  Investments – Equity Method and Joint Ventures. The VIEs are principally private equity limited partnerships in which the Company has invested as a passive limited partner. The partnerships were deemed to be VIEs because the equity holders as a group lack the power to direct the activities that most significantly impact the respective entity’s economic performance. The VIEs generate variability primarily from investment portfolio performance and that variability is passed to equity holders. For these VIEs, the Company absorbs a portion, but not majority, of this variability. These VIEs are reported by the Life Business as a component of other long-term investments in the Statement of Assets and Liabilities.  As of December 31, 2017, the carrying value and maximum exposure to loss arising from unconsolidated VIEs is as follows:

 

Carrying value

 

$

80,618

 

Unfunded commitments

 

25,943

 

Maximum exposure

 

$

106,561

 

 

There is no recourse provision to the general credit of the Company for any VIE beyond the full amount of the Company’s loss exposure.

 

There were no consolidated VIEs as of December 31, 2017.

 

Mortgage Loans

 

The mortgage loan portfolio is comprised entirely of commercial mortgage loans.  The Company’s Life Business is either a participant or co-lender on all loans in the mortgage loan portfolio. As of December 31, 2017, the carrying values of commercial mortgage loans was $834,606.  The number of loans in the portfolio was 4,827 as of December 31, 2017.  The following illustrates the composition of the mortgage loan portfolio by loan to value as of December 31, 2017:

 

 

 

Loan-to-Value

 

Above 95%

 

$

6,187

 

91% to 95%

 

2,276

 

81% to 90%

 

12,111

 

71% to 80%

 

110,985

 

70% and below

 

703,613

 

Allowance for loan losses

 

(566

)

Total

 

$

834,606

 

 

Based upon the historical loss experience and nature of the loan portfolio, the Company believes that a collectively evaluated allowance is inappropriate for its Life Business.  Rather, the Company determines an allowance through an analysis of specific loans that are believed to represent a higher risk of credit impairment.  Since the Company uses a specific identification method for calculating the allowance, it is necessary to review the economic situation of each borrower to determine those that have higher risk of credit impairment.  The Company monitors borrower conditions such as payment practices, borrower credit, operating performance, and property conditions as well as ensuring the timely payment of property taxes and insurance.  If issues are identified through this monitoring process an allowance is established for the loan based on the expected loss.  The expected loss is calculated as the excess carrying value of the loan compared to the fair value of the loan’s underlying collateral, less estimated costs to sell the collateral.   A loan may be subsequently charged off at such point that the Company no longer expects to receive cash payments, the present value of future expected payments of the renegotiated loan is less than the current principal balance, or at such time that the Company is party to foreclosure or bankruptcy proceedings associated with the borrower and does not expect to recover the principal balance of the loan.

 

13



 

A charge off is recorded by eliminating the allowance against the mortgage loan and recording the renegotiated loan or the collateral property related to the loan as investment real estate in the Statement of Assets and Liabilities, which is carried at the lower of the appraised fair value of the property or the unpaid principal balance of the loan, less estimated selling costs associated with the property.

 

As of December 31, 2017, there were no commercial mortgage loans that were foreclosed and converted to real estate properties.  During the year ended December 31, 2017, there were no restructured loans that were classified as a troubled debt restructuring.

 

It is the Company’s policy to cease accruing interest on loans that are over 90 days delinquent. For loans less than 90 days delinquent, interest is accrued unless it is determined that the accrued interest is not collectible. If a loan becomes over 90 days delinquent, it is the Company’s general policy to initiate foreclosure proceedings unless a workout arrangement to bring the loan current is in place. The recorded investment in delinquent loans was insignificant as of December 31, 2017.

 

 

4.                         Reinsurance

 

Certain premiums and benefits are assumed from and ceded to other insurance companies under various reinsurance agreements. Business is ceded to reinsurers to share risks under life and annuity contracts for the purpose of providing increased capacity to write larger risks and maintain exposure to loss within capital resources. The effect of reinsurance assumed and ceded on the Statement of Revenues and Direct Expenses for the year ended December 31, 2017 is as follows:

 

 

Premiums:

 

 

 

Direct

 

$

485,785

 

Assumed

 

9

 

Ceded

 

(93,561

)

 

 

 

 

Net premiums

 

$

392,233

 

 

 

 

 

 

 

 

 

Other income:

 

 

 

Direct

 

$

-

 

Assumed

 

-

 

Ceded

 

33,595

 

 

 

 

 

Net other income

 

$

33,595

 

 

 

 

 

Policyholder benefits and claims:

 

 

 

Direct

 

$

765,281

 

Assumed

 

1,873

 

Ceded

 

(68,545

)

 

 

 

 

Net policyholder benefits and claims

 

$

698,609

 

 

The Company recognized expense allowances in the amount of $33,595 on business ceded to third party reinsurers for the year ended December 31, 2017.

 

Amounts payable or recoverable for reinsurance on policy and contract liabilities are not subject to periodic or maximum limits.

 

Reinsurance receivables, which includes ceded reserve balances and ceded benefit payments, is $324,537 as of December 31, 2017.  The following table illustrates reinsurance receivables attributable to the more significant reinsurance partners as of December 31, 2017:

 

14



 

 

 

Reinsurance

 

 

 

  Receivable

 

 

 

 

 

Swiss Re Life & Health America, Inc.

$

69,353

 

St. James Insurance Company, Ltd.

 

66,293

 

Transamerica

 

65,385

 

RGA Reinsurance Company

 

40,718

 

Commonwealth Union Assurance, Ltd.

 

35,601

 

 

The Company remains obligated for amounts ceded in the event that the reinsurers do not meet their obligations. To minimize its exposure to significant losses from reinsurance insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk arising from similar characteristics of the reinsurers.

 

 

5.                         Deferred Policy Acquisition Costs

 

DAC is attributable to net investment gains (losses) and to other expenses for the amount of gross margins or profits originating from transactions other than investment gains and losses.  Unrealized investment gains and losses represent the amount of DAC that would have been amortized if such gains had been recognized.

 

Details with respect to DAC for the year-ended December 31, 2017 are summarized below:

 

Balance, beginning of year

 

$

463,598

 

 

 

 

 

Additions

 

93,184

 

Amortization

 

(79,353

)

Unlocking

 

1,922

 

Valuation adjustments for unrealized losses on fixed maturities

 

(27,176

)

 

 

 

 

Balance, end of year

 

$

452,175

 

 

 

6.       Sales Inducements

 

The Company provides sales inducements on certain single premium annuity products.  The Company defers the expense associated with the sales inducement each period and amortizes the costs in a manner similar to that used to amortize DAC.

 

Detail with respect to the Company’s deferred sales inducements for the year-ended December 31, 2017 are summarized below:

 

Balance, beginning of year

 

$

10,812

 

 

 

 

 

Additions

 

2,282

 

Amortization

 

(2,233

)

Unlocking

 

(47

)

Valuation adjustments for unrealized losses on fixed maturities

 

(1,633

)

 

 

 

 

Balance, end of year

 

$

9,181

 

 

 

7.                         Separate Accounts

 

Separate accounts represent pension funds, variable life and variable annuity insurance products.  The account

 

15



 

assets primarily consist of other limited partnerships and equity investments which are carried at estimated fair value.  Investment income and changes in asset values do not affect the operating results of the Life Business.  Separate accounts business is maintained independently from the general account of the Life Business.

 

The Company provides administrative services for these contracts.  For the year ended December 31, 2017, fees earned by the Life Business related to these contracts are included in other income in the amount of $628.

 

 

8.                         Commitments and Contingencies

 

The Company guarantees the full and punctual payment when due of any obligations of Liberty Assignment Corporation and BARCO Assignments Ltd (collectively “the owners of the annuity contract”) to the annuity payee, arising out of or in connection with the purchase of the annuity contract.  These guarantees do not result in a material contingent exposure to the Company’s or any related party’s assets or liabilities.   As a result of Lincoln Life’s acquisition of the Company, the guarantee was terminated during 2018.

 

Pursuant to a guarantee agreement effective February 3, 1998 and as amended on March 3, 2006, Liberty unconditionally guarantees to the Company on behalf of and for the benefit of the Company and owners of life insurance and annuity contracts issued by the Company that Liberty will, on demand, make funds available for the timely payment of contractual obligations under any insurance policy or annuity contract issued.  As a result of Lincoln Life’s acquisition of the Company, the guarantee was terminated during 2018.

 

The Company is named as a defendant in various legal actions arising principally from claims made under insurance policies and contracts.  Those actions are considered by the Company in estimating reserves for policy and contract liabilities.  The Company’s management believes that the resolution of those actions will not have a material effect on the financial position or results of operations of the Life Business.

 

The Company is subject to insurance guaranty fund laws in the states in which it transacts its Life Business.  These laws assess insurance companies’ amounts to cover losses to policyholders of insolvent or rehabilitated insurance companies.  In certain states, the assessments may be partially recovered through a reduction in future premium taxes.  At December 31, 2017, premium tax deductions in the amount of approximately $71 were reflected in other assets in the Statement of Assets and Liabilities.  For the year ended December 31, 2017, expenses incurred for guaranty fund assessments, reflected as other expenses in the Statement of Revenue and Direct Expenses, were approximately $23.

 

At December 31, 2017, a guaranty fund prepaid premium tax insolvency asset in the amount of approximately $201 was reflected in other assets in the Statement of Assets and Liabilities.  The prepaid premium tax insolvency asset will be recognized in 2018.

 

As of December 31, 2017, there were unfunded commitments related to other long-term investments reflected in the Statement of Assets and Liabilities.  The unfunded commitments in traditional private equity partnerships, real estate and other investments of $4,050, $108,016, and $57,321, respectively.

 

16



 

9.                         Fair Value of Financial Instruments

 

Fair value is the price that would be received to sell an asset or would be paid to transfer a liability in an orderly transaction between market participants at the measurement date.  In determining fair value, the market approach is primarily used, which generally utilizes market transaction data for identical or similar instruments.

 

The hierarchy level assigned to each security in the available for sale portfolio is based upon an assessment of the transparency and reliability of the inputs used in the valuation of each instrument at the measurement date. The highest priority is given to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Securities are classified based on the lowest level of input that is significant to the fair value measurement. Transfers between levels are recognized at the end of each reporting period. The three hierarchy levels are defined as follows:

 

· Level 1 — Valuations based on unadjusted quoted market prices in active markets for identical assets or liabilities.

 

· Level 2 — Valuations based on observable inputs (other than Level 1 prices), such as quoted prices for similar assets or liabilities at the measurement date, quoted prices in markets that are not active, or other inputs that are observable, either directly or indirectly.

 

· Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement and involve management judgment.  The unobservable inputs reflect estimates of the assumptions that market participants would use in valuing the assets and liabilities.

 

The availability of observable inputs can vary from financial instrument to financial instrument and is affected by a wide variety of factors, including, for example, the type of financial instrument, whether the financial instrument is new and not yet established in the marketplace, and other characteristics particular to the financial instrument.  To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires significantly more judgment.  Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level 3.

 

The Company is responsible for the determination of fair value and the supporting assumptions and methodologies for its Life Business.  The Company gains assurance on the overall reasonableness and consistent application of valuation methodologies and inputs and compliance with accounting standards through the execution of various processes and controls designed to ensure that the Company’s assets and liabilities are appropriately valued.  For fair values received from third parties or internally estimated, the Company’s processes are designed to determine that the valuation methodologies and inputs are appropriate and consistently applied, the assumptions are reasonable and consistent with the objective of determining fair value, and the fair values are accurately recorded. For example, on a continuing basis, the Company assesses the reasonableness of individual fair values that have stale security prices or that exceed certain thresholds as compared to previous fair values received from valuation service providers or brokers or derived from internal models.  The Company performs procedures to understand and assess the methodologies, processes and controls of valuation service providers.  In addition, the Company may validate the reasonableness of fair values by comparing information obtained from valuation service providers or brokers to other third party valuation sources for selected securities.

 

The Company used the following methods and assumptions in estimating the fair value of financial instruments of its Life Business as well as the general classification of such financial instruments pursuant to the above fair value hierarchy:

 

Fixed Maturities

 

At each valuation date, various valuation techniques are used to estimate the fair value of the fixed maturities portfolio.  The primary method for valuing these securities is through independent third-party valuation service providers.  For positions where valuations are not available from independent third-party valuation service providers, broker quotes and internal pricing methods are used to determine fair values.  A single non-binding price quote from a broker familiar with the security who, similar to the Company’s valuation service providers, may consider transactions or activity in similar securities, as applicable, among other information.  The brokers

 

17



 

providing price quotes are generally from the brokerage divisions of leading financial institutions with market making, underwriting and distribution expertise regarding the security subject to valuation.  The evaluation and prioritization of these valuation sources is systematic and predetermined resulting in a single quote or price for each financial instrument.  The following describes the techniques generally used to determine the fair value of fixed maturities by asset class:

 

U.S. Government and Agency Securities

 

U.S. government and agency securities consist primarily of bonds issued by the U.S. Treasury and mortgage pass-through agencies such as the Federal Home Loan Bank, the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation.  As the fair values of the U.S. Treasury securities held by the Life Business are based on active markets and unadjusted market prices, they are classified within Level 1.  The fair value of U.S. government agency securities is generally determined using observable market inputs that include quoted prices for identical or similar assets in markets that are not active, benchmark yields, reported trades, bids, offers and credit spreads. Accordingly, the fair value of U.S. government agency securities is classified within Level 2.

 

Mortgage-Backed Securities

 

The portfolio of residential and commercial MBS is originated by both agencies and non-agencies, the majority of which are pass-through securities issued by U.S. government agencies.  The fair value of MBS is generally determined using observable market inputs that include quoted prices for identical or similar assets in markets that are not active, benchmark yields, contractual cash flows, prepayment speeds, collateral performance and credit spreads. Accordingly, the fair value of MBS is primarily classified within Level 2.

 

Asset-Backed Securities

 

ABS include mostly investment-grade bonds backed by pools of loans with a variety of underlying collateral, including automobile loan receivables, credit card receivables, and collateralized loan obligation securities originated by a variety of financial institutions.  The fair value of ABS is generally determined using observable market inputs that include quoted prices for identical or similar assets in markets that are not active, benchmark yields, contractual cash flows, prepayment speeds, collateral performance and credit spreads. Accordingly, the fair value of ABS is primarily classified within Level 2.

 

Municipal Securities

 

The municipal portfolio is comprised of bonds issued by U.S. domiciled state and municipal entities. The fair value of municipal securities is generally determined using observable market inputs that include quoted prices for identical or similar assets in markets that are not active, benchmark yields, binding broker quotes, issuer ratings, reported trades and credit spreads.  Accordingly, the fair value of municipal securities is primarily classified within Level 2.

 

Corporate Debt and Other Securities

 

Corporate debt securities consist primarily of investment-grade debt of a wide variety of corporate issuers and industries. The fair value of corporate and other securities is generally determined using observable market inputs that include quoted prices for identical or similar assets in markets that are not active, benchmark yields, new issuances, issuer ratings, reported trades of identical or comparable securities, bids, offers and credit spreads.  Accordingly, the fair value of corporate and other securities is primarily classified within Level 2. In the event third-party vendor valuation is not available, prices are determined using non-binding price quotes from a broker familiar with the security. In this instance, the valuation inputs are generally unobservable and the fair value is classified within Level 3.

 

18



 

Foreign Government Securities

 

Foreign government securities include bonds issued or guaranteed by foreign governments. The fair value of foreign government securities is generally determined using observable market inputs that include quoted prices for identical or similar assets in markets that are not active, benchmark yields, binding broker quotes, issuer ratings, reported trades of identical or comparable securities and credit spreads.  Accordingly, the fair value of foreign government securities is primarily classified within Level 2. In the event third-party vendor valuation is not available, prices are determined using non-binding price quotes from a broker familiar with the security. In this instance, the valuation inputs are generally unobservable and the fair value is classified within Level 3.

 

Equity Securities

 

Equity securities is comprised of preferred stocks. The fair value of preferred stock is generally determined using observable market inputs that include quoted prices for identical or similar assets in markets that are not active.  Accordingly, the fair value of preferred stock is primarily classified within Level 2.

 

Other Long-term Investments

 

Other long-term investments include equity investments in privately held businesses. Equity investments in privately held businesses are valued using internal management estimates; they are categorized within Level 3 of the hierarchy.  Limited partnerships, which represent the remainder of the other investment balance on the accompanying Statement of Assets and Liabilities are not subject to these disclosures and therefore are excluded from the table in this note.

 

Separate account assets

 

Separate account assets, which primarily consist of other limited partnerships and equity securities, are measured based on the methodologies discussed above. The activity in separate account assets is offset by an equal amount for separate account liabilities, which results in a net zero impact for the Company. Separate account assets within Level 3 include other limited partnership interests. Other limited partnership interests are valued giving consideration to the value of the underlying holdings of the partnerships.

 

Assets and Liabilities Measured at Fair Value on a Recurring Basis

 

The following tables summarize the assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2017:

 

 

 

As of December 31, 2017

 

 

Level 1

 

Level 2

 

Level 3

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government and agency securities

 

$

538

 

$

412,688

 

$

-

 

$

413,226

Residential MBS

 

-

 

386,811

 

-

 

386,811

Commercial MBS

 

-

 

214,213

 

41,313

 

255,526

Other MBS and ABS

 

-

 

214,310

 

4,963

 

219,273

U.S. state and municipal

 

-

 

3,318,897

 

50,988

 

3,369,885

Corporate and other

 

-

 

8,869,411

 

13,115

 

8,882,526

Foreign government securities

 

-

 

120,054

 

-

 

120,054

 

 

 

 

 

 

 

 

 

Total fixed maturities, available for sale

 

538

 

13,536,384

 

110,379

 

13,647,301

 

 

 

 

 

 

 

 

 

Preferred stock

 

-

 

2,396

 

-

 

2,396

 

 

 

 

 

 

 

 

 

Total equity securities, available for sale

 

-

 

2,396

 

-

 

2,396

 

 

 

 

 

 

 

 

 

Other long-term investments

 

-

 

-

 

15,171

 

15,171

 

19



 

Separate account assets

 

42,917

 

-

 

56,416

 

99,333

 

 

 

 

 

 

 

 

 

Total assets, at fair value

 

$

43,455

 

$

13,538,780

 

$

181,966

 

$

13,764,201

 

 

There were no significant transfers between Levels 1 and 2 during the year ended December 31, 2017.

 

Changes in Level 3 Recurring Fair Value Measurements

 

The following tables summarize the fair values of assets on a recurring basis classified as Level 3 within the fair value hierarchy.

 

 

 

 

 

Net

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance

 

(Losses)

 

 

 

 

 

 

 

Transfer out

 

 

Balance

 

Assets, at Fair Value

 

Jan 1, 2017

 

Gains

 

 

Purchase

 

Maturities

 

 

of Level 3

 

 

Dec.31,2017

Commercial MBS

 

$

40,484

 

$

885

 

 

$

-

 

$

(56

)

 

-

 

 

$

41,313

 

Other MBS and ABS

 

6,139

 

163

 

 

4,975

 

(48

)

 

(6,266

)

 

4,963

 

U.S. state and municipal

 

50,093

 

1,819

 

 

-

 

(924

)

 

-

 

 

50,988

 

Corporate and other

 

10,929

 

(27

)

 

2,416

 

(203

)

 

-

 

 

13,115

 

Total fixed maturities

 

107,645

 

2,840

 

 

7,391

 

(1,231

)

 

(6,266

)

 

110,379

 

Separate account assets

 

69,895

 

(7,551

)

 

-

 

(5,928

)

 

-

 

 

56,416

 

Other long-term investments

 

16,071

 

(404

)

 

-

 

(496

)

 

-

 

 

15,171

 

Total assets

 

$

193,611

 

$

(5,115

)

 

$

7,391

 

$

(7,655

)

 

$

(6,266

)

 

$

181,966

 

 

 

There were no transfers into Level 3 or net realized gains for the year ended December 31, 2017.  Transfers out of Level 3 are primarily due to changes in the observability of pricing inputs.

 

There were no material unrealized gains (losses) for the period included in earnings attributable to the fair value relating to assets and liabilities classified as Level 3 that are still held as of December 31, 2017.

 

Quantitative Information about Level 3 Fair Value Measurements

 

The following table provides information about the significant unobservable inputs used for recurring fair value measurements for certain material Level 3 assets and liabilities and includes only those instruments for which information about the inputs is reasonably available to the Company for its Life Business.  As the input information with respect to certain Level 3 instruments may not be reasonably available, balances shown below may not equal total amounts reported for such Level 3 assets and liabilities.

 

 

 

Fair Value

 

 

 

 

 

Range

 

 

 

At December

 

Valuation

 

Unobservable

 

(Weighted

 

Assets, at Fair Value

 

31,2017

 

Technique(s)

 

Input (*)

 

Average)

 

 

 

 

 

 

 

 

 

 

 

Corporate and other

 

$

10,699

 

Spread Model

 

Credit Spread(a)

 

387-633 (573 bps)

 

 

(a)          An increase in the credit spread will lead to a decrease in fair value and vice versa.

 

Fair Value Measurements on a Non-Recurring Basis

 

There were no assets measured at fair value on a non-recurring basis as of December 31, 2017.

 

Fair Value Option

 

The Company has elected to apply the fair value option to certain financial instruments of the Life Business in limited circumstances.  The fair value option election is made on an instrument by instrument basis.  All periodic changes in the fair value of the elected instruments are reflected in the Statement of Revenues and Direct Expenses as a component of net investment income.  At December 31, 2017, the Company has elected the fair value option for certain investments in limited partnerships which are reflected in other long-term investments in the Statement of Assets and Liabilities.  The fair value of these other long-term investments is

 

20



 

reflected in the “Assets and Liabilities Measured at Fair Value on a Recurring Basis” section above. The impact of the fair value option elections is immaterial to the Life Business of the Company.

 

Financial Instruments Not Carried at Fair Value

 

The fair values and carrying values of financial instruments excluded from ASC 820, Fair Value Measurement, as of December 31, 2017, are as follows:

 

 

 

2017

 

 

 

 

 

Estimated

 

 

 

Carrying

 

Fair

 

 

 

Value

 

Value

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

Other long-term investments

 

$

80,618

 

$

80,618

 

Policy loans

 

131,155

 

131,155

 

Commercial mortgage loans

 

834,606

 

844,309

 

Cash and cash equivalents

 

448,105

 

448,105

 

Other assets

 

2,850

 

2,850

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

Individual annuities

 

3,248

 

3,469

 

Separate account liabilities

 

99,333

 

99,333

 

 

 

Other long-term investments - Fair values, classified as Level 3, represent equity in limited partnerships held by the Life Business. Carrying value of limited partnerships approximates fair value.

 

Policy loans – These instruments are carried at the unpaid principal balances. The fair value of policy loans approximates the unpaid principal balances as the timing of repayment is uncertain and the loans are collateralized by the amount of the policy.  As such, policy loans have been classified as Level 3.

 

Commercial mortgage loans - The fair values of commercial mortgage loans, classified as Level 3, were estimated using option adjusted valuation discount rates or carrying value for newly acquired loans.

 

Cash and cash equivalents - The carrying amounts reported in the accompanying Statement of Assets and Liabilities for these instruments approximate fair values and are classified as Level 1.

 

Other assets – Policy loans, which are categorized as Level 3 fair value measurements, are carried at the unpaid principal balances. The fair value of policy loans approximate the unpaid principal balances as the timing of repayment is uncertain and the loans are collateralized by the amount of the policy.

 

Individual and group annuities - Fair values of liabilities under fixed investment-type insurance contracts, classified as Level 3, are estimated using discounted cash flow calculations at pricing rates as of December 31, 2017.

 

Separate account liabilities - Separate account liabilities represent those balances due to policyholders under contracts that are classified as investment contracts. Separate account liabilities classified as investment contracts primarily represent pension contracts, variable life and variable annuity policies with no significant mortality risk.  As there is no significant mortality risk associated with these contracts, the benefit is equal to the account balance.

 

21



 

Since separate account liabilities are fully funded by cash flows from the separate account assets which are recognized at estimated fair value as described above in the “Assets and Liabilities Measured at Fair Value on a Recurring Basis” section, the value of those assets approximates the estimated fair value of the related separate account liabilities. The valuation techniques and inputs for separate account liabilities are similar to those described for separate account assets.

 

 

10.                 Related Party Transactions

 

Liberty purchases structured settlement annuity contracts, with and without life contingencies from the Company.  Premiums under these contracts amounted to approximately $116,132 for the year ended December 31, 2017.  The related policy and contract reserves with respect to all structured settlement annuity contracts purchased by Liberty was approximately $2,429,935 at December 31, 2017.  Additionally, Liberty funded employee retirement benefits using single premium immediate annuities (SPIA) purchased from the Company.  Premiums under these contracts amounted to approximately $9,617 for the year ended December 31, 2017.

 

11.                 Subsequent Events

 

The Company has evaluated the effects of events subsequent to December 31, 2017, and through the date the Abbreviated Financial Statements were filed with the United States Securities and Exchange Commission.  Other than the transaction discussed in the Note 1 – Description of Transaction and Basis of Presentation, there were no material subsequent events which would warrant inclusion in the Abbreviated Financial Statements of the Life Business.

 

22



 

UNAUDITED PRO FORM A CONDENSED COMBINED FINANCIAL INFORMATION

 

On May 1, 2018, The Lincoln National Life Insurance Company (“Lincoln Life”) completed its previously announced acquisition (the “Closing”) of Liberty Mutual Group Inc.’s (“Liberty”) Group Benefits Business (the “Group Business”) and Individual Life and Annuity Business (the “Life Business”) through the acquisition of all of the issued and outstanding capital stock of Liberty Life Assurance Company of Boston (the “Company”).

 

In connection with the Closing and pursuant to the Master Transaction Agreement, dated January 18, 2018 (the “Master Transaction Agreement”), previously reported in our Current Report on Form 8-K filed on January 23, 2018, Protective Life Insurance Company (“Protective Life”), a wholly owned subsidiary of Protective Life Corporation (“Protective”, “we”), and Protective Life and Annuity Insurance Company (“PLAIC”), a wholly-owned subsidiary of Protective Life, entered into reinsurance agreements (the “Reinsurance Agreements”) and related ancillary documents (including administrative services agreements and transition services agreements) providing for the reinsurance and administration of the Life Business, as defined.  The terms of the Reinsurance Agreement resulted in an acquisition of the Company’s Life Business by Protective Life, in accordance with Accounting Standards Codification (“ASC”) Topic 805, Business Combinations .

 

The following unaudited pro forma condensed combined financial information of Protective Life gives effect to the acquisition as if it had been completed as of January 1, 2017 with respect to the pro forma results of operations data, and as of December 31, 2017 with respect to the balance sheet. We have adjusted the historical consolidated financial information to give effect to pro forma events that are (1) directly attributable to closing the transaction, (2) factually supportable, and (3) with respect to the statements of income, expected to have continuing impact on the combined results.

 

The unaudited pro forma condensed combined financial information below should be read in conjunction with the notes thereto and (1) our audited consolidated financial statements for the year ended December 31, 2017 included in our Annual Report on Form 10-K, as well as (2) the audited abbreviated financial statements of the Life Business for the year ended December 31, 2017, included herein.

 

The abbreviated financial statements of the Life Business include the assets acquired and liabilities associated with the Company’s Life Business as well as all revenue and costs directly associated with the revenue producing activities of the Life Business, and exclude costs not directly involved in the revenue producing activity, such as corporate overhead and income taxes.  Accordingly, the abbreviated financial statements do not purport to present the financial position or operating results of the Company that would have resulted from the Life Business operating as a standalone, separate business.

 

The following unaudited pro forma condensed combined financial information is presented for illustrative purposes only and is not necessarily indicative of what our actual financial position or results of operations would have been had the acquisition been completed on the dates indicated above. In addition, the unaudited pro forma condensed combined financial information does not purport to project the future financial position or operating results of the resulting company. This information does not give effect to (1) our results of operations or other transactions or developments since December 31, 2017, (2) the impact of possible revenue enhancements, expense efficiencies or synergies expected to result from the acquisition, (3) the future acquisition-related costs estimated to integrate  the Life Business operations into Protective Life’s operations and (4) the effects of transactions or developments that may occur subsequent to the acquisition. The foregoing matters could cause both Protective Life’s historical pro forma financial position and results of operations, and Protective Life’s actual future financial position and results of operations, to differ materially from those presented in the following unaudited pro forma condensed combined financial information.

 



 

UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET

(Dollars in Thousands)

 

 

 

As of December 31, 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Protective Life
Insurance
Company

 

Liberty Life
Individual
Business

 

Pro Forma
Adjustments

 

Pro Forma
Combined

 

Assets

 

 

 

 

 

 

 

 

 

Fixed maturities, at fair value

 

$

40,971,486

 

$

13,647,301

 

$

(364,607)

(a)

$

53,831,280

 

 

 

 

 

 

 

(422,900)

(d)

 

 

Fixed maturities, at amortized cost

 

2,718,904

 

 -

 

 

 

2,718,904

 

Equity securities, at fair value

 

715,498

 

2,396

 

(2,396)

(a)

715,498

 

Mortgage loans

 

6,817,723

 

834,606

 

(376,060)

(a)

7,276,867

 

 

 

 

 

 

 

598

(l)

 

 

Investment in real estate, net of accumulated depreciation

 

8,355

 

 -

 

 

 

8,355

 

Policy loans

 

1,615,615

 

131,155

 

 

 

1,746,770

 

Other long-term investments

 

 940,047

 

95,789

 

(158)

(a)

1,035,678

 

Short-term investments

 

527,144

 

 -

 

 

 

527,144

 

Total investments

 

54,314,772

 

14,711,247

 

(1,165,523)

 

67,860,496

 

Cash and cash equivalents

 

178,855

 

448,105

 

110,000

(b)

 

 

 

 

 

 

 

 

(341,520)

(c)

395,440

 

Accrued investment income

 

489,979

 

150,180

 

(2,837)

(a)

637,322

 

Accounts and premiums receivable

 

152,086

 

2,408

 

 

 

154,494

 

Reinsurance receivables

 

4,800,891

 

324,537

 

(75,858)

(n)

4,980,162

 

 

 

 

 

 

 

(69,408)

(o)

 

 

Deferred policy acquisition costs and value of new business acquired

 

2,205,401

 

452,175

 

(224,554)

(e)

2,433,022

 

Goodwill

 

793,470

 

 -

 

 

 

793,470

 

Other intangibles, net of accumulated amortization

 

662,916

 

 -

 

 

 

662,916

 

Property and equipment, net of accumulated depreciation

 

109,711

 

 -

 

 

 

109,711

 

Other assets

 

337,395

 

23,878

 

(23,132)

(a)

338,141

 

Income tax receivable

 

76,986

 

 -

 

 

 

76,986

 

Assets related to separate accounts

 

 

 

 

 

 

 

 

 

Variable annuity

 

13,956,071

 

5,840

 

(5,840)

(a)

13,956,071

 

Variable universal life

 

1,035,202

 

37,077

 

(37,077)

(a)

1,035,202

 

Pensions

 

 -

 

56,416

 

(56,416)

(a)

 -

 

Total Assets

 

79,113,735

 

16,211,863

 

(1,892,165)

 

93,433,433

 

Liabilities

 

 

 

 

 

 

 

 

 

Future policy benefits and claims

 

30,956,792

 

5,901,753

 

685,991

(f)

43,158,665

 

 

 

 

 

 

 

5,614,129

(k)

 

 

Unearned premiums

 

751,130

 

 -

 

52,233

(k)

803,363

 

Total policy liabilities and accruals

 

31,707,922

 

5,901,753

 

6,352,353

 

43,962,028

 

Policyholder account balances

 

 -

 

7,333,659

 

(7,333,659)

(k)

 -

 

Other policy claims and benefits payable

 

 -

 

41,478

 

(41,478)

(k)

 -

 

Stable value product account balances

 

4,698,371

 

 -

 

 

 

4,698,371

 

Annuity account balances

 

10,921,190

 

 -

 

1,708,775

(k)

12,629,965

 

Other policyholders’ funds

 

1,267,198

 

95,168

 

 

 

1,362,366

 

Other liabilities

 

1,859,254

 

145,424

 

6,225

(m)

2,010,903

 

Deferred income taxes

 

1,371,989

 

 -

 

 

 

1,371,989

 

Non-recourse funding obligations

 

2,952,822

 

 -

 

 

 

2,952,822

 

Secured financing liabilities

 

1,017,749

 

341,520

 

(341,520)

(c)

1,017,749

 

Debt

 

1,682

 

 -

 

110,000

(b)

111,682

 

Liabilities related to separate accounts

 

 

 

 

 

 

 

 

 

Variable annuity

 

13,956,071

 

5,840

 

(5,840)

(a)

13,956,071

 

Variable universal life

 

1,035,202

 

37,077

 

(37,077)

(a)

1,035,202

 

Pensions

 

 -

 

56,416

 

(56,416)

(a)

 -

 

Total liabilities

 

70,789,450

 

13,958,335

 

361,363

 

85,109,148

 

Shareowner’s Equity

 

 

 

 

 

 

 

 

 

Preferred stock

 

2

 

 -

 

 

 

2

 

Common stock

 

5,000

 

 -

 

 

 

5,000

 

Additional paid-in-capital

 

7,378,496

 

 -

 

 

 

7,378,496

 

Retained earnings

 

916,971

 

 

 

 

 

916,971

 

Accumulated other comprehensive income

 

 

 

 -

 

 

 

 

 

Net unrealized gains (losses) on investments, net of tax

 

23,091

 

 -

 

 

 

23,091

 

Net unrealized losses relating to other-than- temporary impaired investments for which a portion has been recognized in earnings, net of income tax

 

(22)

 

 -

 

 

 

(22)

 

Accumulated loss - derivatives, net of income tax

 

747

 

 -

 

 

 

747

 

Net assets and liabilities

 

 -

 

2,253,528

 

 

 

 -

 

 

 

 

 

 

 

(769,190)

(a)

 

 

 

 

 

 

 

 

(422,900)

(d)

 

 

 

 

 

 

 

 

(224,554)

(e)

 

 

 

 

 

 

 

 

(685,991)

(f)

 

 

 

 

 

 

 

 

598

(l)

 

 

 

 

 

 

 

 

(6,225)

(m)

 

 

 

 

 

 

 

 

(75,858)

(n)

 

 

 

 

 

 

 

 

(69,408)

(o)

 

 

Total shareowner’s equity

 

8,324,285

 

2,253,528

 

(2,253,528)

 

8,324,285

 

Total liabilities and shareowner’s equity

 

$

79,113,735

 

$

16,211,863

 

$

(1,892,165)

 

$

93,433,433

 

 



 

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENTS OF INCOME

(Dollars in Thousands)

 

 

 

Year Ended December 31, 2017

 

 

 

 

 

Protective Life

Insurance

Company

 

Liberty Life

Individual

Business

 

Pro Forma

Adjustments

 

Pro Forma

Combined

 

Revenues

 

 

 

 

 

 

 

 

 

Premiums and policy fees

 

$

3,456,362

 

$

485,794

 

 

 

$

3,942,156

 

Reinsurance ceded

 

(1,367,096)

 

(93,561)

 

 

 

(1,460,657)

 

Net of reinsurance ceded

 

2,089,266

 

392,233

 

-    

 

2,481,499

 

Net investment income

 

1,923,056

 

624,217

 

$

(49,009)

(g)

2,498,264

 

Universal life and investment type product policy fees

 

-    

 

104,506

 

 

 

104,506

 

Cost of insurance

 

-    

 

80,690

 

 

 

80,690

 

Realized investment gains (losses):

 

 

 

 

 

 

 

 

 

Derivative financial instruments

 

(137,041)

 

-    

 

 

 

(137,041)

 

All other investments

 

121,087

 

51,435

 

 

 

172,522

 

Other-than-temporary impairment losses

 

(1,332)

 

(563)

 

 

 

(1,895)

 

Portion recognized in other comprehensive income (before taxes)

 

(7,780)

 

-    

 

 

 

(7,780)

 

Net impairment losses recognized in earnings

 

(9,112)

 

(563)

 

-    

 

(9,675)

 

Other income

 

325,411

 

31,956

 

 

 

357,367

 

Total revenues

 

4,312,667

 

1,284,474

 

(49,009)

 

5,548,132

 

Benefits and expenses

 

 

 

 

 

 

 

 

 

Benefits and settlement expenses, net of reinsurance ceded

 

2,955,005

 

698,609

 

(22,817)

(p)

3,630,797

 

Interest credited to policyholder account balances

 

-    

 

236,628

 

 

 

236,628

 

Amortization of deferred policy acquisition costs and value of new business acquired

 

79,443

 

77,431

 

(62,864)

(h)

94,010

 

Policyholder dividends

 

-    

 

5,030

 

 

 

5,030

 

Other operating expenses, net of reinsurance ceded

 

814,211

 

100,684

 

3,608

(i)

918,503

 

Total benefits and expenses

 

3,848,659

 

1,118,382

 

(82,073)

 

4,884,968

 

Income before income tax

 

464,008

 

166,092

 

33,064

 

663,164

 

Income tax (benefit) expense

 

(718,409)

 

-    

 

11,903

(j)

(706,506)

 

Net Income

 

$

1,182,417

 

$

166,092

 

$

21,161

 

$

1,369,670

 

 



 

NOTES TO THE UNAUDITED PRO FORMA CONDENSED

COMBINED FINANCIAL INFORMATION

 

Note 1 – Basis of Pro Forma Presentation

 

The unaudited pro forma condensed combined balance sheet was prepared to reflect the transaction as of December 31, 2017. The unaudited pro forma condensed combined statement of income combines the results of operations of Protective Life and the Life Business for the year ended December 31, 2017 as if the transaction had occurred on January 1, 2017.

 

The abbreviated financial statements of the Life Business include the assets and liabilities associated with the Company’s Life Business as well as all revenue and costs directly associated with the revenue producing activities of the Life Business, and exclude costs not directly involved in the revenue producing activity, such as corporate overhead and income taxes. Accordingly, the pro forma condensed combined income statement is not indicative of the acquired business’s operations going forward because of the changes in the business and the omission of various operating expenses.

 

The transaction was accounted for under the acquisition method of accounting. Under this method of accounting, the acquired net assets of the Life Business were recorded based upon the estimated fair values of the Life Business assets and liabilities at the date of completion of the acquisition. The transaction did not result in goodwill being recognized. The unaudited pro forma condensed combined financial information includes adjustments, which are based upon preliminary estimates, to reflect the estimated fair value of all identifiable assets and liabilities of the Life Business as of December 31, 2017. The preliminary purchase price consisted of  a ceding commission of $422.9 million paid as of the closing date. Final adjustments of the estimated fair value of all identifiable assets and liabilities are to be made within 150 days after closing. These final adjustments may result in an adjustment to the preliminary purchase price. Certain amounts in the historical financial statements of the Life Business have been reclassified to conform to Protective Life’s historical financial statement presentation.

 

Estimated fair values and lives have been assigned to the acquired assets and liabilities assumed for the purposes of this unaudited pro forma condensed combined financial information. The unaudited pro forma condensed combined financial information reflects Protective Life’s estimates of the fair value of the net assets of the Life Business as of December 31, 2017.

 

Note 2 – Pro Forma Adjustments

 

These pro forma adjustments are based on certain estimates and assumptions as of the date of the unaudited pro forma condensed combined financial information. The actual adjustments upon the consummation of the acquisition were based on a number of factors, including changes in the estimated fair value of net assets from December 31, 2017 to the effective date of the acquisition. Therefore, the actual adjustments were different from the adjustments made to prepare the unaudited pro forma condensed combined financial information.

 

Pro Forma Acquisition Adjustments

 

For purposes of the unaudited pro forma condensed combined balance sheet, the acquired assets and liabilities have been adjusted to reflect their estimated fair values as of and for the periods presented. Specific adjustments are as follows:

 

(a)          To  reflect assets and liabilities retained by Liberty. Although the accompanying abbreviated financial statements included assets and liabilities associated with the Company’s Life Business, not all of these assets and liabilities were transferred to Protective Life.  For example assets in excess of that needed to support insurance liabilities transferred to Protective Life were retained by Liberty.

(b)          To reflect surplus notes issued at closing. These surplus notes are associated with liabilities related to certain structured settlements included in the Life Business.

(c)           To eliminate securities lending liability settled prior to closing.

(d)          To give effect to the ceding commission paid at closing.

(e)           To eliminate historic deferred policy acquisition costs and to establish value of business acquired.

(f)            To adjust the policy liabilities of the acquired business to reflect estimated fair value.

(g)           To reflect a reduction in investment income related to investments retained by seller. The effective yield assumed for each type of investment retained by seller was:  fixed maturities – 4.0%, equity securities – 2.0%, mortgage loans – 4.5%.  The weighted average was approximately 4.2%

(h)          Represents the estimated change in amortization resulting from the adjustment described in (e) above. Amounts related to traditional life and health insurance policies are amortized over the premium-payment period of the related

 



 

policies in proportion to the ratio of annual premium income to the present value of the total anticipated premium income. Amounts related to universal life and investment products are amortized over the lives of the policies in relation to the present value of estimated gross profits before amortization. Estimated amortization for each of the next five years is as follows: 2018: (18,993), 2019: (18,996), 2020: (17,993), 2021: (16,531), 2022: (14,981)

(i)              To reflect interest expense on surplus notes described in (b) above assuming an interest rate of 3.28%.

(j)             Estimated effective income tax rate for 2017 of 36% (federal 35% plus state 1%).

(k)          To reclassify amounts in the financial statements of the Life Business to conform to Protective Life’s historical financial statement presentation.

(l)              To adjust mortgage loans acquired by Protective Life to fair value at December 31, 2017.

(m)      To record estimated accrued transaction fees. These fees primarily consist of broker, legal, and other professional fees.

(n)          To adjust reinsurance receivables to estimated fair value.

(o)          To reflect reinsurance recaptured at Closing. At December 31, 2017, the Company had ceded certain insurance reserves to one of its affiliates that was recaptured concurrent with Closing.

(p)          Estimation of the impact of the amortization of the difference between the fair value and historical basis of the policy reserves.

 



PART C

OTHER INFORMATION

Item 24. Financial Statements and Exhibits.

(a)  Financial Statements:

All required financial statements are included in Part A and Part B of this Registration Statement.

(b)  Exhibits:

1.  Resolution of the Board of Directors of Protective Life Insurance Company authorizing establishment of the Protective Life Variable Annuity Separate Account (2)

2.  Not applicable

3.  (a)  Form of Underwriting Agreement among Protective Life Insurance Company, Investment Distributors, Inc. and the Protective Life Variable Annuity Separate Account (2)

  (i)  Second Amended Distribution Agreement between IDI and PLICO (22)

  (ii)  Second Amended Distribution Agreement between IDI and PLICO, as Revised June 1, 2018 (24)

(b)  Form of Distribution Agreement between Investment Distributors, Inc. and broker-dealers (2)

4.  (a)  Form of Individual Flexible Premium Deferred Variable and Fixed Annuity Contract (8)

(b)  Form of Group Flexible Premium Deferred Variable and Fixed Annuity Contract (8)

(c)  Participant Certificate for Use with Group Flexible Premium Deferred Variable and Fixed Annuity Contract — All Allocation Options (8)

(d)  Annual Bonus Endorsement (8)

(e)  Waiver of Surrender Charge Endorsement (8)

(f)  Guaranteed Account Endorsement (8)

(g)  Return of Purchase Payments Death Benefit Rider (8)

(h)  Asset-Based Fee Endorsement (8)

(i)  Net Amount at Risk Fee Endorsement (8)

(j)  Minimum Annuitization Value Endorsement (8)

(k)  Annuitization Bonus Endorsement (8)

(l)  Contract Schedule for Individual Contracts (8)

(m)  Maximum Anniversary value Death Benefit Endorsement (10)

(n)  Benefit Based Fee Endorsement (10)

(o)  Form of Guaranteed Lifetime Withdrawal Benefit Rider (13)

(p)  Form of Enhanced GMWB Withdrawal Percentage for Certain Medical Conditions Endorsement (13)

(q)  Lifetime Guaranteed Minimum Withdrawal Benefit Rider with Annual Roll-up (15)

(r)  Nursing Home Endorsement for the Guaranteed Minimum Withdrawal Benefit (16)

(s)  Lifetime GMWB Rider with SecurePay Advantage (18)

(t)  Lifetime Guaranteed Minimum Withdrawal Benefit Rider with Annual Step-Up (18)

5.  Form of Contract Application for Individual Flexible Premium Deferred Variable and Fixed Annuity Contract (8)

6.  (a)  Charter of Protective Life Insurance Company. (1)

(b)  By-Laws of Protective Life Insurance Company. (1)

(c)  2002 Amended and Restated Charter of Protective Life Insurance Company (14)

(d)  2002 Amended and Restated By-Laws of Protective Life Insurance Company (14)

(e)  2011 Amended and Restated Charter of Protective Life Insurance Company (21)


C-1



(f)  2011 Amended and Restated Bylaws of Protective Life Insurance Company (21)

7.  Form of Reinsurance Agreement between Protective Life Insurance Company and Connecticut General Life Insurance Company. (4)

8.  (a)  Participation/Distribution Agreement (Protective Investment Company) (2)

(b)  Participation Agreement (Oppenheimer Variable Account Funds) (3)

(c)  Participation Agreement (MFS Variable Insurance Trust) (3)

(d)  Participation Agreement (Calvert Group, formerly Acacia Capital Corporation) (3)

(e)  Participation Agreement (Van Eck Worldwide Insurance Trust) (5)

(f)  Participation Agreement (Van Kampen Life Investment Trust) (6)

(g)  Participation Agreement (Lord Abbett Series Fund) (7)

(h)  Participation Agreement for Class II Shares (Van Kampen) (4)

(i)  Form of Participation Agreement for Service Class Shares (Oppenheimer Variable Account Funds) (4)

(j)  Form of Participation Agreement for Service Class Shares (Universal Institutional Funds, Inc.) (4)

(k)  Form of Amended and Restated Participation Agreement (MFS Variable Insurance Trust) (4)

(l)  Form of Participation Agreement (Goldman Sachs Variable Insurance Trust) (8)

  (i)  Amendment to Participation Agreement re Summary Prospectus (Goldman Sachs Variable Insurance Trust) (20)

(m)  Participation Agreement (Fidelity Variable Insurance Products) (11)

(n)  Participation Agreement (Franklin Templeton Variable Insurance Products Trust) (12)

  (i)  Amendment to Participation Agreement re Summary Prospectus (Franklin Templeton Variable Insurance Products Trust) (20)

(o)  Amended and Restated Participation Agreement (Fidelity Variable Insurance Products) (12)

(p)  Rule 22c-2 Shareholder Information Agreement (Calvert Group) (14)

(q)  Rule 22c-2 Shareholder Information Agreement (Fidelity Variable Insurance Products) (14)

(r)  Rule 22c-2 Shareholder Information Agreement (Franklin Templeton Variable Insurance Products Trust) (14)

(s)  Rule 22c-2 Shareholder Information Agreement (Goldman Sachs Variable Insurance Trust) (14)

(t)  Rule 22c-2 Shareholder Information Agreement (Lord Abbett Series Fund) (14)

(u)  Rule 22c-2 Shareholder Information Agreement (MFS Variable Insurance Trust) (14)

(v)  Rule 22c-2 Shareholder Information Agreement (Oppenheimer Variable Account Funds) (14)

(w)  Rule 22c-2 Shareholder Information Agreement (Universal Institutional Funds, Inc.) (14)

(x)  Rule 22c-2 Shareholder Information Agreement (Van Kampen Life Investment Trust) (14)

(y)  Form of Rule 22c-2 Agreement (Van Eck Worldwide Insurance Trust) (14)

(z)  Participation Agreement (American Funds Insurance Series) (17)

(aa)  Rule 22c-2 Shareholder Information Agreement (American Funds Insurance Series) (17)

(bb)  Participation Agreement (Legg Mason) (19)

(cc)  Participation Agreement (Royce Capital) (19)

(dd)  Participation Agreement (PIMCO) (19)

  (i)   Form of Novation of and Amendment to Participation Agreement (PIMCO Variable Insurance Trust) (20)

  (ii)  Form of Amendment to Participation Agreement re Summary Prospectuses (PIMCO Variable Insurance Trust) (20)

(ee)  Rule 22c-2 Information Sharing Agreement (Royce) (19)

(ff)  Participation Agreement (AIM Variable Insurance Funds (Invesco Variable Insurance Funds)) (20)

9.  Opinion and Consent of Steve M. Callaway, Esq. (9)


C-2



10.  (a)  Consent of Eversheds Sutherland (US) LLP (24)

(b)  Consent of PricewaterhouseCoopers LLP (24)

(c)  Consent of Ernst & Young LLP (24)

11.  No financial statements will be omitted from Item 23

12.  Not applicable

13.  Powers of attorney (23)

(1)   Incorporated herein by reference to the initial filing of the Form N-4 Registration Statement, (File No. 33-70984) filed with the Commission on October 28, 1993.

(2)   Incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement, (File No. 33-70984) filed with the Commission on February 23, 1994.

(3)   Incorporated herein by reference to Post-Effective Amendment No. 5 to the Form N-4 Registration Statement, (File No. 33-70984) filed with the Commission on April 30, 1997.

(4)   Incorporated herein by reference to Post-Effective Amendment No. 47 to the Form N-4 Registration Statement, (File No. 333-94047), filed with the Commission on April 30, 2003.

(5)   Incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement, (File No. 333-60149) filed with the Commission on October 26, 1998.

(6)   Incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-4 Registration Statement, (File No. 33-70984) filed with the Commission on April 20, 2000.

(7)   Incorporated herein by reference to Post-Effective Amendment No. 3 to the Form N-4 Registration Statement (File No. 333-94047), filed with the Commission on April 25, 2002.

(8)   Incorporated herein by reference to the initial Registration Statement on Form N-4 (File No. 333-112892), filed with the Commission on February 17, 2004.

(9)   Incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-112892), filed with the Commission on May 3, 2004.

(10)   Incorporated herein by reference to the initial filing of the Form N-4 Registration Statement (File No. 333-115212), filed with the Commission on May 6, 2004.

(11)   Incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-107331), filed with the Commission on November 26, 2003.

(12)   Incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-116813), filed with the Commission on April 28, 2006.

(13)   Incorporated herein by reference to Post-Effective Amendment No. 4 to the Form N-4 Registration Statement (File No. 333-116813), filed with the Commission on March 2, 2007.

(14)   Incorporated herein by reference to Post-Effective Amendment No.17 to the Form N-4 Registration Statement (File No. 33-70984), filed with the Commission on April 27, 2007.

(15)   Incorporated herein by reference to Post-Effective Amendment No. 7 to the Form N-4 Registration Statement (File No. 333-115212), filed with the Commission on January 3, 2008.

(16)   Incorporated herein by reference to Post-Effective Amendment No. 10 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on February 29, 2008.

(17)   Incorporated herein by reference to Post-Effective Amendment No. 11 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on April 30, 2008.

(18)   Incorporated herein by reference to Post-Effective Amendment No. 11 to the Form N-4 Registration Statement (File No. 333-112892), filed with the Commission on April 29, 2009.

(19)   Incorporated herein by reference to Post-Effective Amendment No. 15 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on October 28, 2009.

(20)   Incorporated herein by reference to Post Effective Amendment No. 19 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on April 25, 2011.


C-3



(21)   Incorporated herein by reference to Post-Effective Amendment No. 8 to the Form N-4 Registration Statement (File No. 333-153041), filed with the Commission on September 16, 2011.

(22)   Incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-190294) filed with the Commission on April 25, 2014.

(23)   Incorporated herein by reference to Post-Effective Amendment No. 25 to the Form N-4 Registration Statement (File No. 333-112892), filed with the Commission on April 24, 2018.

(24)   Filed herewith.

Item 25. Directors and Officers of Depositor.

Name and Principal Business Address*

 

Position and Offices with Depositor

 
Adams, D. Scott
 
  Executive Vice President, Chief Digital and
Innovation Officer
 

Bedwell, Robert R. III

 

Senior Vice President, Mortgage Loans

 
Bielen, Richard J.
 
 
 
 
  Director
Executive Committee
Chief Executive Officer
Chairman of the Board
President
 
Black, Lance P.
 
  Treasurer
Senior Vice President
 
Borie, Kevin B.
 
 
  Senior Vice President
Chief Valuation Actuary
Appointed Actuary
 
Callaway, Steve M.
 
 
 
  Chief Compliance Officer
Senior Vice President
Secretary
Senior Counsel
 

Cirulli, Vincent

 

Senior Vice President, Derivatives and VA Hedging

 
Cyphert, Mark
 
  Senior Vice President
Chief Information and Operations Officer
 
Drew, Mark L.
 
  Executive Vice President
General Counsel
 
Evesque, Wendy L.
 
  Senior Vice President
Chief Human Resources Officer
 

Flint, Christopher W.

 

Senior Vice President, Distribution Companies

 

Goyer, Stephane

 

Senior Vice President, Insurance, Market and Credit Risk

 
Harrison, Wade V.
 
  Senior Vice President
Chief Product Actuary
 
Herring, Derry W
 
  Senior Vice President
Chief Auditor
 
Kane, Nancy
 
  Senior Vice President, Acquisitions and
Corporate Development
 

Karchunas, M. Scott

 

Senior Vice President, Asset Protection Division

 
Kohler, Matthew
 
  Senior Vice President
Chief Technology Officer
 
Loper, David M
 
  Senior Vice President
Senior Counsel
 
Moloney, Michelle
 
  Senior Vice President
Chief Risk Officer
 


C-4



Name and Principal Business Address*

 

Position and Offices with Depositor

 
Passafiume, Philip E.
 
  Senior Vice President
Director of Fixed Income
 
Riebel, Matthew A.
 
  Senior Vice President
Chief Sales Officer
 

Sawyer, John Robert

 

Senior Vice President, Life and Annuity Executive

 

Seurkamp, Aaron C.

 

Senior Vice President, Life and Annuity Executive

 
Stokes, Barrie Balzli
 
  Senior Vice President, Government Affairs
Senior Associate Counsel
 
Stuenkel, Wayne E.
 
  Senior Vice President
Chief Actuary
 
Temple, Michael G.
 
 
  Director
Executive Committee
Vice Chairman, Finance and Risk
 
Thigpen, Carl S.
 
 
  Director
Executive Vice President
Chief Investment Officer
 

Wagner, James

 

Senior Vice President, Annuity Sales

 
Walker, Steven G.
 
  Executive Vice President
Chief Financial Officer
 
Wells, Paul R.
 
 
  Chief Accounting Officer
Controller
Senior Vice President
 

Whitcomb, John

 

Senior Vice President, Distribution Operations

 

Williams, Lucinda S.

 

Senior Vice President, Customer Experience

 

*  Unless otherwise indicated, principal business address is 2801 Highway 280 South, Birmingham, Alabama 35223.

Item 26.  Persons Controlled by or Under Common Control With the Depositor or the Registrant.

The registrant is a segregated asset account of the Company and is therefore owned and controlled by the Company. All of the Company's outstanding voting common stock is owned by Protective Life Corporation, a subsidiary of Dai-ichi Life Insurance Company, Limited. Protective Life Corporation is described more fully in the prospectus included in this registration statement. Various companies and other entities controlled by Protective Life Corporation may therefore be considered to be under common control with the registrant or the Company. Such other companies and entities, together with the identity of their controlling persons (where applicable), are set forth in Exhibit 21 to Form 10-K of Protective Life Corporation for the fiscal year ended December 31, 2017 (File No. 1-11339) filed with the Commission March 2, 2018.

Item 27. Number of Contractowners.

As of June 30, 2018, there were 23,040 contract owners of ProtectiveValues individual and group flexible premium deferred variable and fixed annuity contracts offered by Registrant.


C-5



Item 28. Indemnification of Directors and Officers.

Article XI of the By-laws of Protective Life provides, in substance, that any of Protective Life's directors and officers, who is a party or is threatened to be made a party to any action, suit or proceeding, other than an action by or in the right of Protective Life, by reason of the fact that he is or was an officer or director, shall be indemnified by Protective Life against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such claim, action, suit or proceeding if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of Protective Life and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. If the claim, action or suit is or was by or in the right of Protective Life to procure a judgment in its favor, such person shall be indemnified by Protective Life against expenses (including attorneys' fees) actually and reasonably incurred by him in connection with the defense or settlement of such action or suit if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of Protective Life, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable for negligence or misconduct in the performance of his duty to Protective Life unless and only to the extent that the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper. To the extent that a director or officer has been successful on the merits or otherwise in defense of any such action, suit or proceeding, or in defense of any claim, issue or matter therein, he shall be indemnified by Protective Life against expenses (including attorneys' fees) actually and reasonably incurred by him in connection therewith, not withstanding that he has not been successful on any other claim issue or matter in any such action, suit or proceeding. Unless ordered by a court, indemnification shall be made by Protective Life only as authorized in the specific case upon a determination that indemnification of the officer or director is proper in the circumstances because he has met the applicable standard of conduct Such determination shall be made (a) by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to, or who have been successful on the merits or otherwise with respect to, such claim action, suit or proceeding, or (b) if such a quorum is not obtainable, or, even if obtainable a quorum of disinterested directors so directs, by independent legal counsel in a written opinion or (c) by the shareholders.

In addition, the executive officers and directors are insured by PLC's Directors' and Officers' Liability Insurance Policy including Company Reimbursement and are indemnified by a written contract with PLC which supplements such coverage.

Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

Item 29. Principal Underwriter.

(a)  Investment Distributors, Inc. ("IDI") is the principal underwriter of the Contracts as defined in the Investment Company Act of 1940. IDI is also principal underwriter for the Protective Variable Life Separate Account and Variable Annuity Account A of Protective Life.


C-6



(b)  The following information is furnished with respect to the officers and directors of Investment Distributors, Inc.

Name and Principal
Business Address*
 

Position and Offices

 

Position and Offices with Registrant

 
Brown, Barry K.
Caldwell, Edwin V. II
Callaway, Steve M.
 
Debnar, Lawrence J.
Gilmer, Joseph F.
 
Johnson, Julena G.
 
Majewski, Carol L.
 
Morsch, Letitia
Tennent, Rayburn
  Assistant Secretary
President and Director
Chief Compliance Officer,
Secretary and Director
Assistant Financial Officer
Assistant Financial Officer
and Director
Assistant Compliance
Officer
Assistant Compliance
Officer
Assistant Secretary
Chief Financial Officer
     

*  Unless otherwise indicated, principal business address is 2801 Highway 280 South, Birmingham, Alabama 35223.

(c)  The following commissions were received by each principal underwriter, directly or indirectly, from the Registrant during the Registrant's last fiscal year:

(1) Name of Principal
Underwriter
  (2) Net Underwriting
Discounts and Commissions
  (3) Compensation on
Redemption
  (4) Brokerage
Commissions
  (5) Other
Compensation
 

Investment Distributors, Inc.

   

N/A

     

None

     

N/A

     

N/A

   

Item 30. Location of Accounts and Records.

All accounts and records required to be maintained by Section 31(c) of the Investment Company Act of 1940 and the rules thereunder are maintained by Protective Life Insurance Company at 2801 Highway 280 South, Birmingham, Alabama 35223.

Item 31. Management Services.

All management contracts are discussed in Part A or Part B.

Item 32. Undertakings.

(a)  Registrant hereby undertakes to file a post-effective amendment to this registration statement as frequently as is necessary to ensure that the audited financial statements in the registration statement are never more than sixteen (16) months old for so long as payments under the variable annuity contracts may be accepted.

(b)  Registrant hereby undertakes to include either (1) as part of any application to purchase a contract offered by the Prospectus, a space that an applicant can check to request a Statement of Additional Information, or (2) a postcard or similar written communication affixed to or included in the Prospectus that the applicant can remove to send for a Statement of Additional Information.

(c)  Registrant hereby undertakes to deliver any Statement of Additional Information and any financial statement required to be made available under this Form promptly upon written or oral request.


C-7



(d)  The Company represents that in connection with its offering of the Contracts as funding vehicles for retirement plans meeting the requirements of Section 403(b) of the Internal Revenue Code of 1986, it is relying on a no-action letter dated November 28, 1988, to the American Council of Life Insurance (Ref. No. IP-6-88) regarding Sections 22(e), 27(c)(1), and 27(d) of the Investment Company Act of 1940, and that paragraphs numbered (1) through (4) of that letter will be complied with.

(e)  Protective Life hereby represents that the fees and charges deducted under the Contract, in the aggregate, are reasonable in relation to the services rendered, the expenses expected to be incurred, and the risks assumed by Protective Life.


C-8



SIGNATURES

Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant of this Registration Statement certifies that it meets the requirements of Securities Act Rule 485(b) for effectiveness of this Registration Statement and has duly caused this Post-Effective Amendment to the Registration Statement on Form N-4 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Birmingham, State of Alabama, on July 20, 2018.

  PROTECTIVE VARIABLE ANNUITY SEPARATE ACCOUNT

By:  *

  Richard J. Bielen, President
  Protective Life Insurance Company

  PROTECTIVE LIFE INSURANCE COMPANY

By:  *

  Richard J. Bielen, President
  Protective Life Insurance Company

As required by the Securities Act of 1933, this amendment to the Registration Statement on Form N-4 has been signed by the following persons in the capacities and on the dates indicated:

Signature  

Title

 

Date

 
*
Richard J. Bielen
 

Chairman of the Board, President, Chief Executive Officer, and Director (Principal Executive Officer)

 

July 20, 2018

 
*
Steven G. Walker
  Executive Vice President,
and Chief Financial Officer (Principal Financial Officer)
 

July 20, 2018

 
*
Carl S. Thigpen
 

Executive Vice President, Chief Investment Officer, and Director

 

July 20, 2018

 
*BY: /S/ MAX BERUEFFY
Max Berueffy
Attorney-in-Fact
   

July 20, 2018

 


C-9



Exhibit Index

3.(a)(ii)  Second Amended Distribution Agreement between IDI and PLICO, as Revised June 1, 2018

10.(a)  Consent of Eversheds Sutherland (US) LLP

10.(b)  Consent of PricewaterhouseCoopers, LLP

10.(c)  Consent of Ernst & Young LLP



Exhibit 99.3(a)(ii)

 

Second Amended

DISTRIBUTION AGREEMENT

As Revised June 1, 2018

 

This DISTRIBUTION AGREEMENT originally dated as of September 21, 1998, by and between PROTECTIVE LIFE INSURANCE COMPANY (“Insurer”), a life insurance company organized and existing under the laws of the State of Tennessee, on its behalf and on behalf of each separate account identified in Schedule 1 hereto, and INVESTMENT DISTRIBUTORS, INC. (“Distributor”), a corporation organized and existing under the laws of the State of Tennessee, is entered into this 24 th  day of October, 2013, and revised June 1, 2018.

 

WITNESSETH:

 

WHEREAS, Distributor is a broker-dealer that engages in the distribution of investment products including variable insurance products;

 

WHEREAS, Insurer and Distributor entered into a principal underwriting agreement dated as of September 21, 1998 (the “Original Agreement”) for the distribution of Insurer’s insurance products that are registered with the Securities and Exchange Commission; and

 

WHEREAS, Insurer and Distributor desire to amend and restate in its entirety the Original Agreement to clarify the duties and responsibilities of the parties (such Original Agreement, as amended and restated hereby, this “Agreement”).

 

NOW, THEREFORE, in consideration of their mutual promises, Insurer and Distributor hereby agree as follows:

 

1.                                       Definitions

 

a.                                       Contracts — The class or classes of variable and other insurance products issued by Insurer that are

 

(i)             “securities” as defined in section 2(a)(1) of the 1933 Act and not otherwise exempted from the provisions of the 1933 Act; and

 

(ii)            set forth on Schedule 1 to this Agreement, and such other classes of insurance products issued by Insurer that may be added to Schedule 1 from time to time in accordance with Section 12.b of this Agreement, including any riders or endorsements to such products.

 

For this purpose and under this Agreement generally, a “class of Contracts” shall mean those Contracts issued by Insurer on the same policy form or forms and covered by the same Registration Statement.

 

b.                                       Registration Statement — At any time that this Agreement is in effect, the currently effective registration statement filed with the SEC under the 1933 Act on a prescribed form, or currently effective post-effective amendment thereto, as

 



 

the case may be, relating to a class of Contracts, including financial statements included in, and all exhibits to, such registration statement or post-effective amendment.  The term “Registration Statement,” when it appears in singular form, shall refer to each Registration Statement for a class of Contracts under this Agreement.  For purposes of Section 9 of this Agreement, the term “Registration Statement” means any document which is or at any time was a Registration Statement within the meaning of this Section 1.b.

 

c.                                        Prospectus — The prospectus included within a Registration Statement, except that, if the most recently filed version of the prospectus (including any supplements thereto) filed pursuant to Rule 497 or 424, as applicable, under the 1933 Act subsequent to the date on which a Registration Statement became effective differs from the prospectus included within such Registration Statement at the time it became effective, the term “Prospectus” shall refer to the most recently filed prospectus filed under Rule 497 or 424, as applicable, under the 1933 Act, from and after the date on which it shall have been filed.  The term “Prospectus,” when it appears in singular form, shall refer to each Prospectus for a class of Contracts under this Agreement.  For purposes of Section 9 of this Agreement, the term “any Prospectus” means any document which is or at any time was a Prospectus within the meaning of this Section 1.c.

 

e.                                        Separate Account — A separate account supporting a class or classes of Variable Contracts and specified on Schedule 1 as in effect at the time the Original Agreement was executed, or as it has been and may be amended from time to time in accordance with Section 12.b of this Agreement.  The term “Separate Account,” when it appears in singular form, shall refer to each Separate Account listed on Schedule 1.

 

f.                                         1933 Act — The Securities Act of 1933, as amended.

 

g.                                        1934 Act — The Securities Exchange Act of 1934, as amended.

 

h.                                       1940 Act — The Investment Company Act of 1940, as amended.

 

i.                                           SEC — The Securities and Exchange Commission.

 

j.                                          FINRA — The Financial Industry Regulatory Authority, Inc.

 

k.                                       FINRA Rules  — The rules adopted by FINRA, including supplementary material thereto and interpretations thereof.

 

l.                                           State Insurance Commission — A commission, agency or other governmental body charged by the legislature of a state or commonwealth of the United States or the District of Columbia with the regulation of insurance.

 

m.                                   State Securities Commission — A commission, agency or other governmental

 



 

body charged by the legislature of a state or commonwealth of the United States or the District of Columbia with the regulation of securities.

 

n.                                       Regulations — The rules and regulations promulgated by the SEC under the 1933 Act, the 1934 Act and the 1940 Act as in effect at the time this Agreement is executed or thereafter promulgated.

 

o.                                       Selling Agreement — An agreement among Insurer, Distributor and Selling Broker-Dealer pursuant to which Selling Broker-Dealer is authorized to engage in retail solicitation activities with respect to the offering of the Contracts.

 

p.                                       Selling Broker-Dealer — A person registered as a broker-dealer and licensed as an insurance producer or associated with a person so licensed, and authorized to engage in retail solicitation activities with respect to the offering of the Contracts pursuant to a Selling Agreement as provided for in Section 2 of this Agreement.

 

q.                                       Wholesaling Agreement — An agreement among Insurer, Distributor and Wholesaling Broker-Dealer pursuant to which Wholesaling Broker-Dealer is authorized to engage in wholesaling activities with respect to the offering of the Contracts.

 

r.                                          Wholesaling Broker-Dealer — A person registered as a broker-dealer and licensed as a life insurance producer or associated with a person so licensed, and authorized to engage in wholesaling activities with respect to the offering of the Contracts pursuant to a Wholesaling Agreement as provided for in Section 2 of this Agreement.

 

s.                                         Representative — When used with reference to Distributor, Selling Broker-Dealer or Wholesaling Broker-Dealer, an individual who is an associated person thereof, as the term “person associated with a broker or dealer” is defined in the 1934 Act.

 

t.                                          Contract Service Center — The service center identified in the Prospectus as the location at which premiums, applications and other orders and instructions for the Contracts are accepted.

 

u.                                       State — A state, commonwealth or other jurisdiction or territory of the United States, including the District of Columbia.

 

v.                                       Variable Contracts — Contracts that are variable annuity contracts or variable life insurance contracts.

 

2.                                       Authorization and Appointment

 

a.                                       Scope of Authority .  Insurer hereby authorizes Distributor to serve as non-exclusive principal underwriter on an agency basis for the public offering of the Contracts, and Distributor hereby agrees to act as such.  Insurer reserves the right

 



 

to appoint additional underwriters.  Distributor shall actively engage in its duties under this Agreement on a continuous basis while the Registration Statement for the Contracts is effective, consistent with its business and subject to applicable material market and regulatory conditions and any other restrictions that may become applicable to its activities.  Insurer reserves the right at any time to suspend or limit the public offering of the Contracts, upon written notice to Distributor.  It is understood that Distributor has no present intention of engaging in solicitation activities for the Contracts on a retail basis, and intends to restrict its distribution activities to authorizing other broker-dealers to engage in wholesaling activities and/or retail solicitation activities for the public offering of the Contracts.

 

b.                                       Authorization of Selling Broker-Dealers .  Distributor will authorize Selling Broker-Dealers to solicit applications and premiums for the Contracts on a retail basis directly from purchasers who are their customers, subject to the provisions of this Agreement.  Such authority shall be granted pursuant to Selling Agreements in the form attached hereto, with such modifications as Insurer and Distributor may agree upon from time to time.  Insurer alone shall be responsible for appointing Selling Broker-Dealers and all Representatives of Selling Broker-Dealers selling the Contracts on their behalf as producers of Insurer in accordance with applicable State insurance law and for communicating to all Selling Broker-Dealers and their personnel, all policies and procedures applicable to them as such appointed producers of Insurer.

 

c.                                        Authorization of Wholesaling Broker-Dealers .  Insurer and Distributor may authorize one or more Wholesaling Broker-Dealers to engage in wholesaling activities on their behalf for the purpose of soliciting broker-dealers to enter into Selling Agreements and supporting Selling Broker-Dealers and their Representatives in connection with the retail solicitation of the Contracts.  Distributor may provide information and marketing assistance to any Wholesaling Broker-Dealer.  Insurer alone shall be responsible for appointing Wholesaling Broker-Dealer and its Representatives as producers of Insurer in accordance with applicable State insurance law and for communicating to Wholesaling Broker-Dealer and its personnel, all policies and procedures applicable to them as such appointed producers of Insurer.

 

d.                                       Limits on Authority .  Distributor shall act as an independent contractor and nothing herein contained shall constitute Distributor or its agents, officers or employees as agents, officers or employees of Insurer solely by virtue of their activities in connection with the distribution of the Contracts hereunder.  Distributor and its Representatives shall not have authority, on behalf of Insurer:  to make, alter or discharge any Contract or other insurance policy or annuity contract entered into pursuant to a Contract; to waive any Contract forfeiture provision; to extend the time of paying any premium; or to receive any monies or premiums (except for the sole purpose of forwarding monies or premiums to Insurer).  Distributor shall not expend, nor contract for the expenditure of, the

 



 

funds of Insurer.  Distributor shall not possess or exercise any authority on behalf of Insurer other than that expressly conferred on Distributor by this Agreement.  Neither Distributor nor any Distributor Representative shall give any information or make any representation in regard to the Contracts in connection with the offer or sale of such Contracts that is not in accordance with the Prospectus or statement of additional information for such Contracts, or in the then-currently effective prospectus or statement of additional information for an investment vehicle for the Contracts, or in current advertising materials for such class of Contracts authorized by Insurer.

 

e.                                        Collection of Premiums .  Given the scope of Distributor’s activities hereunder, it is not anticipated that Distributor would collect or receive premiums for the Contracts.  However, to the extent that Distributor or a Distributor Representative receives a premium, such premium shall be remitted promptly, and in any event not later than two business days, in full, together with any applications, forms and any other required documentation, to the Contract Service Center.  Checks or money orders in payment of premiums shall be drawn to the order of “Protective Life Insurance Company.”  If any premium is held at any time by Distributor, Distributor shall hold such premium in a fiduciary capacity until remitted.  Distributor acknowledges that all such premiums, whether by check, money order or wire, shall be the property of Insurer.  Distributor acknowledges that Insurer shall have the unconditional right to reject, in whole or in part, any application or premium.

 

3.                                       Distributor’s Representations, Warranties and Undertakings .  Distributor represents and warrants to Insurer that:

 

a.                                       Distributor is registered as a broker-dealer under the 1934 Act, is a member of FINRA, and is duly registered under applicable State securities laws, and that Distributor is in compliance in all material respects with the requirements of the 1934 Act, Section 9(a) of the 1940 Act, FINRA Rules and State securities laws applicable to Distributor as a registered broker-dealer.

 

b.                                       Any Distributor Representatives required to be registered with FINRA and any State Securities Commission as representatives or principals of Distributor are so registered.

 

c.                                        Distributor shall continue to comply, and shall undertake to cause its Representatives to comply, in all material respects, during the term of this Agreement, with applicable requirements of the 1934 Act, Section 9(a) of the 1940 Act, FINRA Rules, and any State securities laws.

 

4.                                       Insurer’s Representations and Warranties Regarding SEC Filings .  Insurer represents and warrants to Distributor on the date that each Registration Statement becomes effective that:

 



 

a.                                       SEC Filings .  Insurer has filed with the SEC all statements, notices, and other documents required for registration of the Contracts covered by such Registration Statement under the provisions of the 1933 Act and Regulations thereunder, and, if such Registration Statement covers Variable Contracts, registration of the related Separate Account under the provisions of the 1940 Act and Regulations thereunder, and has obtained all necessary or customary orders of exemption or approval from the SEC to permit the distribution of the Contracts pursuant to this Agreement and, if such Registration Statement covers Variable Contracts, to permit the establishment and operation of the related Separate Account as contemplated in such Registration Statement and in conformity with the 1940 Act and Regulations thereunder, which orders, to the extent required, apply to Distributor, as principal underwriter for the public offering of the Contracts and for the Separate Account.

 

b.                                       Effectiveness .  Such Registration Statement has been declared effective by the SEC or has become effective in accordance with applicable Regulations.  Insurer has not received any notice from the SEC with respect to such Registration Statement pursuant to Section 8(e) of the 1940 Act, and no stop order under the 1933 Act has been issued, and no proceeding therefor has been instituted or threatened by the SEC.

 

c.                                        Compliance with 1933 Act and 1940 Act .  Such Registration Statement and related Prospectus comply in all material respects with applicable provisions of the 1933 Act and Regulations thereunder and, if such Registration Statement covers Variable Contracts, also comply in all material respects with applicable provisions of the 1940 Act and Regulations thereunder, and neither such Registration Statement nor Prospectus contains an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading, in light of the circumstances in which they were made; provided, however, that none of the representations and warranties in this Section 4.c shall apply to statements or omissions from such Registration Statement or Prospectus made in reliance upon and in conformity with information furnished to Insurer in writing by Distributor expressly for use therein.

 

d.                                       Contracts Duly Authorized .  The Contracts covered by such Registration Statement have been duly authorized by Insurer and conform to the descriptions thereof in such Registration Statement and related Prospectus and, when issued as contemplated by such Registration Statement and related Prospectus, shall constitute legal, validly issued and binding obligations of Insurer in accordance with their terms.  The form of the Contracts and, where applicable, the Separate Account have each been duly approved to the extent required by the Tennessee insurance commission and by the State Insurance Commission in every other State other than New York, or otherwise have been cleared for the issuance of the Contracts in such State.

 



 

e.                                        Separate Account .  If such Registration Statement covers Variable Contracts, the related Separate Account has been duly established by Insurer and conforms to the description thereof in the Registration Statement and related Prospectus.

 

f.                                         Tax Compliance .  The Contracts qualify as annuity contracts or life insurance contracts, as applicable, under applicable federal tax laws.

 

g.                                        Duly Authorized .  Insurer is duly organized as a life insurance company under the laws of the State of Tennessee and is duly authorized to conduct a life insurance business in all States in which the Contracts may be offered.

 

6.                                       Insurer’s Undertakings .  For so long as the Contracts are being offered and remain outstanding, Insurer undertakes as follows:

 

a.                                       Securities Law Compliance .  Insurer shall be responsible for preparing the Prospectuses and Registration Statements for each class of Contracts and filing them with the SEC and State Securities Commissions, to the extent required.  Insurer shall use its best efforts to maintain the registration of the Contracts and, in the case of Variable Contracts, the related Separate Accounts with the SEC and any applicable State Securities Commission, such efforts to include, without limitation, best efforts to prevent a stop order from being issued by the SEC or any such State Securities Commission or, if a stop order has been issued, to cause such stop order to be withdrawn.  In the case of Variable Contracts, Insurer shall take all action required to cause the related Separate Accounts to continue to comply, in all material respects, with the provisions of the 1940 Act and regulations and exemptions thereunder applicable to the Separate Accounts as a registered investment company under the 1940 Act.  Insurer shall not deduct any amounts from the assets of any Separate Account, enter into a transaction or arrangement involving the Variable Contracts or the related Separate Account, or cause any Separate Account to enter into any such transaction or arrangement, without obtaining any necessary or customary approvals or exemptions from the SEC or no-action assurance from the SEC staff, and without ensuring that such approval, exemption or assurance applies to Distributor as the principal underwriter for such Separate Account and Contracts.  Insurer shall timely file each post-effective amendment to a Registration Statement, Prospectus, statement of additional information, Rule 24f-2 notice, annual report on Form N-CEN, and all other reports, notices, statements, and amendments required to be filed by or for Insurer and/or a Separate Account with the SEC under the 1933 Act, the 1934 Act and/or the 1940 Act or any Regulations, and shall pay all filing or registration fees payable in connection therewith.  To the extent there occurs an event or development (including, without limitation, a change of applicable law, regulation or administrative interpretation) warranting an amendment to either the Registration Statement or supplement to the Prospectus, Insurer shall endeavor to prepare, subject to Distributor’s right to review such material provided in Section 6(b), and file such amendment or supplement with the SEC with all deliberate speed.

 



 

b.                                       Provision of Copies .  Distributor shall have the right to review any Registration Statement or Prospectus.  Upon Distributor’s request, Insurer shall provide Distributor with a preliminary draft of any exemptive application or no-action request to be filed with the SEC in connection with the Contracts and/or, in the case of Variable Contracts, the related Separate Account.  Insurer shall furnish Distributor with copies of any such material or amendment thereto, as filed with the SEC, promptly after the filing thereof, and any SEC communication or order with respect thereto, promptly after receipt thereof.  Insurer shall maintain and keep on file in its principal executive office any file memoranda or any supplemental materials referred to in any such Registration Statement, Prospectus, exemptive application and no-action request and shall, as necessary, amend such memoranda or materials and shall provide or otherwise make available copies of such memoranda and materials to Distributor.

 

c.                                        Due Diligence .  Insurer shall provide Distributor access to such records, officers and employees of Insurer at reasonable times as is necessary to enable Distributor to fulfill its obligation, as the underwriter under the 1933 Act for the Contracts and, in the case of Variable Contracts, as principal underwriter for the related Separate Account under the 1940 Act, to perform due diligence and to use reasonable care.

 

d.                                       State Insurance Law Compliance .  Insurer shall be responsible for preparing the Contract forms and filing them with applicable State Insurance Commissions, to the extent required.  Insurer shall obtain and maintain approvals of the Contracts and the Separate Account (including for purposes of this Section 6.d only any separate account established with respect to Contracts that are not Variable Contracts) from State Insurance Commissions, to the extent required, in order to carry out the offering of the Contracts in all States other than New York.  Insurer shall take all action required to cause the Contracts to continue to comply, in all material respects, as annuity contracts or life insurance contracts, as applicable, under applicable State insurance laws.  Insurer shall file promotional, sales and advertising material for the Contracts and Separate Account, to the extent required, with State Insurance Commissions.

 

e.                                        Federal Tax Law Compliance .  Insurer shall take all action required to cause the Contracts to continue to comply, in all material respects, as annuity contracts or life insurance contracts, as applicable, under applicable federal tax laws.

 

f.                                         Issuance and Administration of Contracts .  Insurer shall be responsible for issuing the Contracts and administering the Contracts and the Separate Accounts, provided, however, that Distributor shall have full responsibility for the securities activities of all persons employed by Insurer, who are engaged directly or indirectly in the Contract operations and are identified as associated persons of Distributor, and shall have full responsibility for the training, supervision and control of such persons to the extent of such activities.

 



 

g.                                        Marketing Materials .  Insurer shall be responsible for furnishing Distributor, Wholesaling Broker-Dealers and Selling Broker-Dealers with such applications, Prospectuses and other materials for use in their activities with respect to the Contracts.  Insurer shall notify Distributor and any Selling Broker-Dealers of those States which require delivery of a statement of additional information with a prospectus to a prospective purchaser.

 

h.                                       Confirmations .  Insurer, as agent for Selling Broker-Dealers, shall confirm to each applicant for and purchaser of a Contract in accordance with Rule 10b-10 under the 1934 Act acceptance of premiums and such other transactions as are required to be confirmed by Rule 10b-10 or administrative interpretations thereunder.

 

i.                                           Books and Records .  Insurer shall maintain and preserve the books and records in connection with the offer and sale of the Contracts, including without limitation the compensation records provided for in Section 8.a of this Agreement, in conformity with the requirements of Rule 17a-3 and 17a-4 under the 1934 Act, to the extent that such requirements are applicable to the Contracts.  Insurer acknowledges and agrees that all such books and records are maintained and held by Insurer on behalf of and as agent for Distributor whose property they are and shall remain, and that such books and records are at all times subject to inspection by the SEC in accordance with Section 17(a) of the 1934 Act.

 

6.                                       Other Obligations of the Parties

 

a.                                       Anti-Money Laundering .  The parties shall comply with applicable anti-money laundering laws, regulations, rules and government guidance, including the reporting, record keeping and compliance requirements of the Bank Secrecy Act (“BSA”), as amended by The International Money Laundering Abatement and Financial Anti-Terrorism Act of 2002, Title III of the USA PATRIOT Act (the “Patriot Act”), its implementing regulations, and related SEC rules, including without limitations, Customer Identification Program (“CIP”) rules.  Further, the parties shall comply with the economic sanctions programs administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”).  To the extent required by applicable law, the Parties will promptly notify one another whenever suspicious activity or OFAC matches are detected.

 

b.                                       Trading Practices .  Each party represents that it has and maintains an internal control structure for the processing and transmission of orders suitably designed (a) to prevent orders received after the close of trading on the New York Stock Exchange from being aggregated with orders received before such close of trading and (b) to minimize errors that could result in late transmission of orders to Insurer.  The parties further represent, warrant and covenant that they have adopted reasonable procedures to prevent customers from providing false or otherwise inaccurate information with respect to the source of the trading activity for any customer account or engaging in market timing activity in any account.

 


 


 

The parties shall cooperate with one another to reject future purchases by customers who engage in any of the trading activities described in this paragraph.

 

c.                                        Privacy .  The parties each affirm that they have procedures in place reasonably designed to protect the privacy of non-public customer information and will maintain such information they acquire pursuant to this Agreement in confidence and in accordance with all applicable privacy laws.  “Confidential Information” includes, by way of example and not limitation, all client-related information (including the names, addresses, telephone numbers, social security numbers and account numbers of such referred clients, as well as non-public personal information of such clients) that the parties receive.  Notwithstanding the foregoing, each Party shall have the right to use or disclose Confidential Information: (i) to the full extent required to comply with applicable laws or requests of regulators; (ii) as necessary in connection with the Party’s audit, legal, compliance or accounting procedures; (iii) as necessary or permitted by applicable laws in the ordinary course of business under this Agreement; (iv) as authorized by a customer; and (v) to protect against or prevent fraud.  Confidential Information does not include (i) information which is now generally available in the public domain or which in the future enters the public domain through no fault of the receiving party; (ii) information that is disclosed to the receiving party by a third party without violation by such third party of an independent obligation of confidentiality of which the receiving party is aware; or (iii) information that the disclosing party consents in writing that the receiving party may disclose.

 

7.                                       Notification of Contractholder Complaints and Developments

 

a.                                       Contractholder Complaints .  Insurer and Distributor shall notify the other promptly of any substantive complaint received by either party with respect to Insurer, Distributor, any Distributor Representative or employee or with respect to any Contract.  The parties hereto shall cooperate in investigating such complaint and any response by either party to such complaint shall be sent to the other party for written approval not less than five business days prior to its being sent to the customer or any regulatory authority, except that if a more prompt response is required, the proposed response shall be communicated by telephone or facsimile.  In any event, neither party shall release any such response without the other party’s prior written approval.

 

b.                                       Developments .  Insurer and Distributor shall notify the other upon the happening of any material event, if known by such notifying party, which makes untrue any material statement made in the Registration Statement or Prospectus or which requires the making of a change therein in order to make any statement made therein not materially misleading.  In addition, Insurer shall notify Distributor immediately or in any event as soon as possible under the circumstances of the following:

 

(1)                                  If Insurer becomes aware that any Prospectus, sales literature or other

 



 

printed matter or material used in marketing and distributing any Contract contains an untrue statement of a material fact or omits to state a material fact necessary in order to make the statements made therein, in light of the circumstances in which they were made, not misleading;

 

(2)                                  Of any request by the SEC for any amendment to a Registration Statement, for any supplement to the Prospectus, or for additional information;

 

(3)                                  Of the issuance by the SEC of any “stop order” with respect to a Registration Statement or any amendment thereto, or the initiation of any proceedings for that purpose or for any other purpose relating to the registration and/or offering of the Contracts;

 

(4)                                  Of any event of the Contracts’ or a Separate Account’s noncompliance with the applicable requirements of federal tax law or regulations, rulings, or interpretations thereunder that could jeopardize the Contracts’ status as annuity or life insurance contracts, as applicable;

 

(5)                                  Of any change in applicable insurance laws or regulations of any State materially adversely affecting the insurance status of the Contracts or Distributor’s obligations with respect to the distribution of the Contracts; and

 

(6)                                  Of any loss or suspension of the approval of the Contracts or distribution thereof by a State Securities Commission or State Insurance Commission, any loss or suspension of Insurer’s certificate of authority to do business or to issue variable insurance products in any State, or of the lapse or termination of the Contracts’ or a Separate Account’s registration, approval or clearance in any State.

 

c.                                        Regulatory Actions .  Insurer and Distributor shall notify the other in writing upon being apprised of the institution of any proceeding, investigation or hearing involving the offer or sale of the Contracts.  Distributor and Insurer shall cooperate fully in any securities or insurance regulatory investigation or proceeding or judicial proceeding arising in connection with the offering, sale or distribution of the Contracts distributed under this Agreement.

 

8.                                       Compensation and Expenses

 

a.                                       Insurer shall pay Distributor’s expenses as provided in a Management and Administrative Services Agreement between the parties, but shall not otherwise pay any selling compensation to Distributor for its services hereunder.  Insurer shall pay compensation payable under the Wholesaling Agreements and Selling Agreements directly to Wholesaling Broker-Dealers and Selling Broker-Dealers, respectively, or their designees on behalf of Distributor, as a purely ministerial

 



 

service and shall maintain records in respect thereof for Distributor in compliance with applicable requirements under the 1934 Act.

 

b.                                       Insurer shall be responsible for all expenses in connection with:

 

(1)                                  the preparation and filing of each Registration Statement (including each pre-effective and post-effective amendment thereto) and the preparation and filing of each Prospectus (including any preliminary and each definitive Prospectus);

 

(2)                                  the preparation, underwriting, issuance and administration of the Contracts and the payment of benefits thereunder;

 

(3)                                  any registration, qualification or approval or other filing of the Contracts or Contract forms required under the securities or insurance laws of the States in which the Contracts will be offered.

 

(4)                                  all registration fees for the Contracts payable to the SEC and any State Securities Commission; and

 

(5)                                  the printing of all promotional materials, definitive Prospectuses for the Contracts and any supplements thereto for distribution to prospective and existing owners of Contracts.

 

9.                                       Indemnification

 

a.                                       By Insurer .  Insurer shall indemnify and hold harmless Distributor and any of its officers, directors, employees or agents, against any and all losses, claims, damages or liabilities, joint or several (including any investigative, legal and other expenses reasonably incurred in connection with, and any amounts paid in settlement of, any action, suit or proceeding or any claim asserted), to which Distributor and/or any such person may become subject, under any statute or regulation, any FINRA Rule or interpretation, at common law or otherwise, insofar as such losses, claims, damages or liabilities:

 

(1)                                  arise out of or are based upon any untrue statement or alleged untrue statement of a material fact or omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein not misleading, in light of the circumstances in which they were made, contained in any (i) Registration Statement or in any Prospectus or (ii) blue-sky application or other document executed by Insurer specifically for the purpose of qualifying any or all of the Contracts for sale under the securities laws of any State; provided that Insurer shall not be liable in any such case to the extent that such loss, claim, damage or liability arises out of, or is based upon, an untrue statement or alleged untrue statement or omission or alleged omission

 



 

made in reliance upon information furnished in writing to Insurer by Distributor specifically for use in the preparation of any such Registration Statement or any such blue-sky application or any amendment thereof or supplement thereto; or

 

(2)                                  result from any material breach by Insurer of any provision of this Agreement.

 

This indemnification agreement shall be in addition to any liability that Insurer may otherwise have; provided, however, that no person shall be entitled to indemnification pursuant to this provision if such loss, claim, damage or liability is due to the willful misfeasance, bad faith, gross negligence or reckless disregard of duty by the person seeking indemnification.

 

b.                                       By Distributor .  Distributor shall indemnify and hold harmless Insurer and any of its officers, directors, employees or agents, against any and all losses, claims, damages or liabilities, joint or several (including any investigative, legal and other expenses reasonably incurred in connection with, and any amounts paid in settlement of, any action, suit or proceeding or any claim asserted), to which Insurer and/or any such person may become subject under any statute or regulation, any FINRA Rule or interpretation, at common law or otherwise, insofar as such losses, claims, damages or liabilities:

 

(1)                                  arise out of or are based upon any untrue statement or alleged untrue statement of a material fact or omission or alleged omission to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading, in light of the circumstances in which they were made, contained in any (i) Registration Statement or in any Prospectus, or (ii) blue-sky application or other document executed by Insurer specifically for the purpose of qualifying any or all of the Contracts for sale under the securities laws of any State; in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon information furnished in writing by Distributor to Insurer specifically for use in the preparation of any such Registration Statement or any such blue-sky application or any amendment thereof or supplement thereto;

 

(2)                                  result because of any use by Distributor or any Distributor Representative of promotional, sales or advertising material not authorized by Insurer or any verbal or written misrepresentations by Distributor or any Distributor Representative or any unlawful sales practices concerning the Contracts by Distributor or any Distributor Representative under federal securities laws or FINRA Rules; or

 

(3)                                  result from any material breach by Distributor of any provision of this

 



 

Agreement.

 

This indemnification shall be in addition to any liability that Distributor may otherwise have; provided, however, that no person shall be entitled to indemnification pursuant to this provision if such loss, claim, damage or liability is due to the willful misfeasance, bad faith, gross negligence or reckless disregard of duty by the person seeking indemnification.

 

c.                                        General .  Promptly after receipt by a party entitled to indemnification (“indemnified person”) under this Section 9 of notice of the commencement of any action as to which a claim will be made against any person obligated to provide indemnification under this Section 9 (“indemnifying party”), such indemnified person shall notify the indemnifying party in writing of the commencement thereof as soon as practicable thereafter, but failure to so notify the indemnifying party shall not relieve the indemnifying party from any liability which it may have to the indemnified person otherwise than on account of this Section 9.  The indemnifying party will be entitled to participate in the defense of the indemnified person but such participation will not relieve such indemnifying party of the obligation to reimburse the indemnified person for reasonable legal and other expenses incurred by such indemnified person in defending himself or itself.

 

The indemnification provisions contained in this Section 9 shall remain operative in full force and effect, regardless of any termination of this Agreement.  A successor by law of Distributor or Insurer, as the case may be, shall be entitled to the benefits of the indemnification provisions contained in this Section 9.

 

10.                                Term and Termination .  This Agreement shall remain in effect until it is terminated.  This Agreement shall terminate automatically if it is assigned by a party without the prior written consent of the other party.  This Agreement may be terminated at any time for any reason by either party upon six months’ prior written notice to the other party, without payment of any penalty.  (The term “assigned” shall not include any transaction not involving an actual change in management or control.)  This Agreement may be terminated at the option of either party to this Agreement upon the other party’s material breach of any provision of this Agreement or of any representation or warranty made in this Agreement, unless such breach has been cured within 10 days after receipt by the breaching party of notice of breach from the non-breaching party.  Upon termination of this Agreement all authorizations, rights and obligations shall cease except the obligation to settle accounts hereunder.

 

11.                                Notices .  All notices hereunder are to be made in writing and shall be given:

 

if to Insurer, to:

 

Vice President and Managing Director, Annuities

 



 

Protective Life Insurance Company

2801 Highway 280 South

Birmingham, AL 35223

 

With a copy to:

 

Senior Counsel — Variable Insurance Products

Protective Life Corporation

2801 Highway 280 South

Birmingham, AL 35223

 

if to Distributor, to:

 

Chief Executive Officer

Investment Distributors, Inc.

2801 Highway 280 South

Birmingham, AL 35223

 

With a copy to:

 

Senior Counsel — Variable Insurance Products

Protective Life Corporation

2801 Highway 280 South

Birmingham, AL 35223

 

or such other address as such party may hereafter specify in writing.  Each such notice to a party shall be either hand delivered or transmitted by overnight mail by a nationally recognized courier, and shall be effective upon delivery.

 

12.                                General

 

a.                                       Binding Effect .  This Agreement shall be binding on and shall inure to the benefit of the respective successors and assigns of the parties hereto provided that neither party shall assign this Agreement or any rights or obligations hereunder without the prior written consent of the other party in accordance with Section 10 of this Agreement.

 

b.                                       Amendments .  The parties to this Agreement may amend Schedule 1 to this Agreement from time to time to reflect additions of any class of Contracts and any Separate Accounts.  The provisions of this Agreement shall be equally applicable to each such class of Contracts and each Separate Account that may be added to the Schedule and the related Registration Statement and Prospectus, unless the context otherwise requires.  Any other change in the terms or provisions of this Agreement shall be by written agreement between Insurer and Distributor.

 

c.                                        Rights, Remedies, etc, are Cumulative .  The rights, remedies and obligations

 



 

contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under State and federal laws.  Failure of either party to insist upon strict compliance with any of the conditions of this Agreement shall not be construed as a waiver of any of the conditions, but the same shall remain in full force and effect.  No waiver of any of the provisions of this Agreement shall be deemed, or shall constitute, a waiver of any other provisions, whether or not similar, nor shall any waiver constitute a continuing waiver.

 

d.                                       Arbitration .  Any controversy or claim arising out of relating to this Agreement, or the breach hereof, shall be settled by arbitration in accordance with the Commercial Arbitration Rules of the American Arbitration Association, and judgment upon the award rendered by the arbitrator(s) may be entered in any court having jurisdiction thereof.

 

e.                                        Interpretation; Jurisdiction .  This Agreement constitutes the whole agreement between the parties hereto with respect to the subject matter hereof, and supersedes all prior oral or written understandings, agreements or negotiations between the parties with respect to such subject matter.  No prior writings by or between the parties with respect to the subject matter hereof shall be used by either party in connection with the interpretation of any provision of this Agreement, provided, however, that the terms of the Original Agreement shall govern any dispute pertaining to an event that occurred prior to the effective date of the Amendment and Restatement of this Agreement.  This Agreement shall be construed and its provisions interpreted under and in accordance with the internal laws of the State of Tennessee without giving effect to principles of conflict of laws.

 

f.                                         Severability.   This is a severable Agreement.  In the event that any provision of this Agreement would require a party to take action prohibited by applicable federal or State law or prohibit a party from taking action required by applicable federal or State law, then it is the intention of the parties hereto that such provision shall be enforced to the extent permitted under the law, and, in any event, that all other provisions of this Agreement shall remain valid and duly enforceable as if the provision at issue had never been a part hereof.

 

g.                                        Section and Other Headings; Plurality .  The headings in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.  Unless otherwise indicated, terms used in the singular form shall include the plural form and vice versa.

 

h.                                       Counterparts.   This Agreement may be executed in two or more counterparts, each of which taken together shall constitute one and the same instrument.

 

i.                                           Regulation .  This Agreement shall be subject to the provisions of the 1933 Act,

 



 

1934 Act and 1940 Act and FINRA Rules, from time to time in effect, including such exemptions from the 1940 Act as the SEC may grant, and the terms hereof shall be interpreted and construed in accordance therewith.

 

IN WITNESS WHEREOF, the parties hereto have caused this Amended and Restated Agreement to be duly executed by such authorized officers on the date specified above.

 

 

PROTECTIVE LIFE INSURANCE COMPANY

 

 

 

 

 

By:

 

 

Name:

 

 

Title:

 

 

 

 

INVESTMENT DISTRIBUTORS, INC.

 

 

 

 

 

By:

 

 

Name:

 

 

Title:

 

 



 

SCHEDULE 1

 

SEPARATE ACCOUNTS AND CONTRACTS

COVERED BY AGREEMENT

Revised June1, 2018

 

Separate Account Contracts

 

Protective Variable Annuity Separate Account

Protective Variable Annuity

 

Elements Classic

 

Elements Access

 

Elements Plus

 

Protective Advantage

 

Protective Variable Annuity II

 

Mileage Credit

 

ProtectiveValues

 

ProtectiveValues Advantage

 

ProtectiveValues Access

 

Protective Rewards B2A

 

Rewards II

 

Protective Access

 

Protective Elite

 

Protective Access XL

 

Protective Dimensions

 

Protective Variable Annuity, Series B, C and L

 

Protective Investors Series

 

Protective Dimensions II

 

Protective Variable Annuity II B Series

 

Protective Investors Series- ADV

 

Protective Dimensions III

Protective Variable Life Separate Account

Premiere I

 

Executive

 

Premiere II

 

Premiere II 2003

 

Transitions

 

Single Premium Plus

 

Survivor

 

Provider

 

Preserver

 

Preserver II

 

Protector

 

Premiere III

 

Investors Choice

 

Protective Strategic Objectives VUL

First Variable Annuity Fund E

Capital No Load VA

 



 

 

Capital Five VA

 

Capital Six VA

 

Separate Account VL of First Variable Life Insurance Company

Capital Estate Builder VUL

 

Capital Solutions VUL

 

Capital One Pay VL

First Variable Annuity Fund A

Individual Variable Annuity Policies

United Investors Advantage Gold Variable Account

Advantage Gold Deferred Variable Annuity

United Investors Life Variable Account

Advantage I VUL

United Investors Annuity Variable Account

Advantage II Variable Annuity

United Investors Universal Life Variable Account

Advantage Plus VUL

Titanium Universal Life Variable Account

Titanium VUL

Titanium Annuity Variable Account

Titanium VA

United Investors RetireMap Variable Account

United Investors RetireMap

 

Other Registered Products:

 

Protective Prosaver Platinum

Protective Market Defender

 


Exhibit 99.10(a)

 

[EVERSHEDS SUTHERLAND (US) LLP]

 

THOMAS E. BISSET

DIRECT LINE: 202.383.0118

E-mail: ThomasBisset@eversheds-sutherland.com

 

July 20, 2018

 

VIA EDGAR

 

Board of Directors

Protective Life Insurance Company

2801 Highway 280 South

Birmingham, AL 35223

 

Re:           ProtectiveValues Variable Annuity

Post-Effective Amendment No. 26

 

Directors:

 

We hereby consent to the reference to our name under the caption “Legal Matters” in the Statement of Additional Information filed as part of the Registration Statement on Form N-4 (File No. 333- 112892 ) by Protective Life Insurance Company and Protective Variable Annuity Separate Account with the Securities and Exchange Commission.  In giving this consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933.

 

 

Very truly yours,

 

 

 

Eversheds Sutherland (US) LLP

 

 

 

 

 

By:

/s/ Thomas E. Bisset

 

 

Thomas E. Bisset

 


Exhibit 99.10(b)

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in this Registration Statement on Form N-4 of Protective Variable Annuity Separate Account of our report dated April 24, 2018, relating to the financial statements of the subaccounts listed in such report of Protective Variable Annuity Separate Account, which appears in Post-Effective Amendment No. 25 to the Registration Statement on Form N-4.

 

We also consent to the incorporation by reference in this Registration Statement on Form N-4 of Protective Variable Annuity Separate Account of our reports dated March 21, 2018 (“Successor Company”) and March 18, 2016 (“Predecessor Company”), relating to the consolidated financial statements and financial statement schedules of Protective Life Insurance Company and subsidiaries, which appear in Post-Effective Amendment No. 25 to the Registration Statement on Form N-4.

 

/s/ PricewaterhouseCoopers LLP

 

Birmingham, Alabama

July 20, 2018

 


Exhibit 99.10(c)

 

Consent of Independent Auditors

 

We consent to the use of our report dated July 13, 2018 with respect to the abbreviated financial statements of the Individual Life and Annuity Business of Liberty Life Assurance Company of Boston, included in Post-Effective Amendment No. 26 to the Registration Statement (Form N-4 No. 333-112892).

 

/s/ Ernst & Young LLP

Boston, Massachusetts

 

July 20, 2018